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Chapter 1
INTRODUCTION

Progress in the studT ot arterial disease has undergone considerable
evoluticn in the last tiftY' Y'ears.

Advances in depth ot canprehension ot

biological processes among all ot the basic medical sciences has preceded and
conditicned progress in the tield ot arteriosclerosis.

Rapid strides in

anatOll\Y, biochemistry, phy'siology and pharmacology have not onl,y given us
better understanding ot the ftmctim. ot normal living cells, but have also
provided both routes and vehicles by which pathological processes might be
better investigated.

As a consequence ot this progression it has become

increasingl;r evident that arteriosclerosis 18 most likel¥ t.he resultant ot a
multiplicity ot tactors.

These man)" interrelationships require in our opinicn

a multidisciplin8l"1' approach which is problem rather than procedure oriented.
Development ot this dissertatim was conditioned by progress made by'
other investigators as well as by unanswered questions the resolution ot which
it was telt is vital to the appreciation ot the etiology ot arteriosclerosis.
Epinephrine induced arteriopathy has gained greater stature as more recent
studies have demCl.l8trated the interrelationship ot the medial and the adventitial lqers ot the arterial wall.

Two divergent hypotheses have been

advanced to explain the etiology ot epinephrine arteriopathy}
this condition is a CCI'UteQuence

eIle suggests

ot hemodynamic ettects, while a s8Ccnd

bypothesis favors a metabolic etiology.

The obj act ot this dissertaticn was

to determine whether the various dru.g interactions which intensity or
conversel,y ameliorate epinephrine arteriopathy are better explained. on a
biochemical or a vasopressor basis or by an bypothesis combining both ot

these factors.
Stu~

of arteriosclerosis has evolved from

ear~

descriptive phases

defining the fllOrphology and epidezr..101ogy of the lesion to include the most
sophisticated descriptive and quantitative methodology available.

EarlT

investigaticns emphasized the occurrence of' atheranatou8 or Imsh like" lesions
in the arterial wall which presumabl1' were responsible for the mortality

associated with this condition.

Observation of' lipid in the human atheroma

was followed by' Anitschkow' s discovery (1913) that feeding a diet high in
cholesterol to the rabbit produced lesions which. were similar in some respects
to those described 1n humans.
Investigations which followed suggested that generation of the
atherau. represented a distinct and separate form of arterial pathology
l.im1ted :in extent to the intimal or innermost laver of the arterial wall.
Thus, the term atherosclerosis was coined to more clearl;r define and differentiate the atheromatous lesion from other forms of arterial pathology.
Central to this line of inquiry was the tacit assumption that atherosclerosis
was pril'naril;r a consequence of deranged lipid metabolism.

The simpliCity of

this concept has had ccnsiderable appeal.
Discreditaticn of the unitarian theoI1' of atherogenesis resulted
from more precise quantitation and study' of epidemiological data which has
disclosed that deranged lipid metabolism is not a sine qua nan of atherosclerosis.

Ancel (eys (1963) J perhaps the leading proponent of the hyper-

lipemic theory of atherogenesis, h.as recently stated "L'"l the modern era of
increasing sophistication, single cause theories of the etiology of atherosclerosis have given

w~

to the general ccncept of a multiplicity of

influences that promote the disease.

The total atherogenic force is viewed

as the

Sllla

or resultant of a number of environmental factors operating on the

basic genetic endOWlllent".

Similarly', Stamler (1962), lc:ng a respected worker in this field,
has stated "Atherosclerosis is a disease

()f

multifactorial causation.

A large

number of factors, exogenous ar.d endogenous, interact with diet to influence
the development of the (atherosclerotic) lasien".

In supporting this state-

ment Staml.er states that the Frandngham. study in which a large series of
patients 'Were studied in regard to a number of factors such. as blood lipid
hypertension, excessive smoking, obesity etc., seems to indicate that v.hen

two or more of the "defects" were found in any me individual the likelihood
of atherosclerotic corooary diaease occurring was ccns1derably enhanced.
Dole at al. (1963) has recentl,y attacked the lipid theory- stating
"clinicians have overemphasized the importance of plasma lipids.

Challges in

the oomposition of blood plasma are easy to detect but are unreliable as
measures of vascular disease or as guides to treatment.

Arteriosclerosis

occurs without hyperlipemia and byperlipeLlia without vascular lesions".
Changes in concept of the etiology of atherosclerosis haTe been
accompanied by cCllsiderable modificaticn in definition of the nature and
extent of

~le

lesion.

Ear~

nomenclature characterized atherosclerosis as a degenerative

ccndition associa.ted with advanced age in which small pustule-like outpoeket-

ings containing stainable lipid farl/led

arteries.
located

Ql

the intimal or innermost ).qar ot

In contrast, the term medial sclerosis was applied to changes

primar~

in the media. or middle layer of the arterial wall, charac-

terized by degeneration of' the MllSeulariS, fatty degenerat:ton, necrosis and
finaJ.l.y calcium deposition.

More recentl3r, the World Health Organization (1958) has defined
atherosclerosis as Ita variable combination of changes in the intima of
arteries •••••• consisting of focal accumulation of lipids, complex carbohydrates, blood and blood products, fibrous tissue and calcium deposits, and
associated with medial changes".
Although many investigators have characterized arterioaclerosis as
a disease of advancing age, more recent~ ~IcGill et ale (196.3), Taylor (1962)
and others have indicated that this cmditicn has its onset in childhood.
This school of investigators has reported that the earliest lesions are
believed to be fatty streaks occurring in the intima of child:rea and adole.cents.

Thus according to McGill (1963), lipid deposition begins in the aorta

in the first year of life, in the coronaries in the second decade and in the

cerebral ve.sels in the third deCade.

'lhese fatty streaks are seen gross1,y,

in fresh or formalin fixed arterial tissue, as yellow opaque necks or streaks
on the intimal surface.

SeDe of the fatty deposits become covered with a cap

of fibrous connective tissue, forming what is referred. to as the fibrous
plaque.

other fatty streaks are believed to regress without formation of the

fibrous plaque.

According to McGill et ale (1963) it is the fibrous plaque

which sets the .tage for the cl1nicalll' manifested form of arteriosclerosis,
as a result of hemorrhage within the plaque and thrcmbosis over the plaque.
Either of these complications may reduce the size of the lumen, resulting in
angina, DlTocardial infarction, cerebral infarction or peripheral gangrene.
According to Ta,ylor (1962), the arteries of adults usualll" contain both fatty
and fibrous plaques while in the older population fibrous lesims predominate.
Frogressim of the lesion is associated with widening and thickening of the
plaque and lU1' be associated with necrosis and degeneratim of the central

region of the lesion.
lation of

ntany'

Further progressicn of the lesiCll includes the accumu-

small crystals of cholesterol as well as an extension of the

lesial into the media.

With increasing cencentration of lipids within the

foam cells lnany of these cells disintegrate and an acellular mass of lipid and
necrotic debris forms.

This latter accumulation ot cholesterol and other

lipids provides the semi-soft or mushy inclusion which characterizes the
atheroma.

Subsequent changes may include ulcerations of the surface of the

atheroma possibl"v acting as focal point for thrombus fo:r:mation, or hemorrhage
may occur within the plaque.

Ca~cium

salts frequently deposit within the

atherosclerotic plaque, forming fia.kes or plates that may be as large as 1 to
2 em. in diameter.

In some cases the arterial wall may become so

severe~

calcified that the vessel will shatter whp.Il sectioning is attempted.
involvement is, according to Taylor, a

CClUUllOll

Medial

consequence of the progressive

development of intimal atherosclerotic lesions and is frequ.entl¥ found in
atherosclerotic aneur,rsms.
Hus (1962) has stated "it is llkelT that i f calcific medial
degeneraticm could be prevented, other factors which enbance prcgressim ot
most undesiraple atheroarteriosclerot1c changes could be tolerated well by
most people.

It calcific medial degeneration could be prevented , the chain

of reactims arising therefrom could best be m1n1m1zed or interrupted by
measures tor keeping the blood. cholesterol level below 180 m.illigrams per
cent, for preventing unduly increased blood pressure and when indicated tor
reducing the clotting tend.ency of the blood".

In further exposition

ot these

points Bass states that" since lipids invariably aocumulate in the intima of
maJ'l3" parts of the arterial system in older segments of the population, the

idea has arisen that some metabolic abnormality enhances the tendency for

theae substances to accumulate through either a mural mechanism, a change in
the oompositioo of plasma lipids or an increase in their level.

Hasa (1962)

further states that "there is little doubt that the level and cmposition of
the blood lipids especial.l;y cholesterol and its esters are factors in the
development of the disease,

especia~

when the total blood cholesterol level

is long sustained at high levels. But there is no proof that cholesterol or
lipid levels, customary in man are in thellSelves respCllsible for the disease".

The :>."'Gasons which lIass (1962), gives to substantiate his position are as
follows:

1)

there 1s no consistent correspc::ndence between the rate of

progressiCll or severity of the disease and the level of blood cholesterol or
lipids.

2)

The disease ocours eventually in almost everyone irrespeotive of

the magnitude or the auntim of these levela.

.3)

Patients with high

cholesterol levels of 10lg duration mq have less disease than those with
lower levels of sind J fir duration.
Hass {1962} has attempted to resolve the disorepancies between
theoretical oonsiderations and empirioal obserY'ations by formulating a ooncept
which embodies the au.captibUity of the arterial wall to various types of
damage.

For example, all vessels do not undergo medial degeneration and the

degree of oalcification accomp&.n:ying this damage is not consistent, while in
other easElS coexistence of these two phenom.ena are cloae1;y related.

Thus he

feels that it is necessary to charaoterize the susceptibility of each part of
the arterial system to deleterious faotors which may be multiple and not
necessaril3' idelitical1n all systems or in all people.

Sim1lar~,

since

the depooition of lipid varies in both hwn.a.ns and animals as well as within
each species Hass feels there is reason for a.ssuming that the "lipoidosis
potential" or su.sceptibilitY' to lipid deposition of vessels .f'r(Jll different

indh"iduals

.1ltq V8>ry.

Another facet of Hass' theory encompasses the "mesen-

chymal reaction p'otentinl".

He indicates that in the course of medial degen-

eration the deteriorative changes may activate mesenchymA in the media,
adjacent intima, and ad.ventitia.

The s1.1bsequent :L'1crease in oollagen and

activa.tion. of 1mma.ture vascular mesenchyme assists in repair of the media.
S1milarJ;r, activatim of mesenchyme in the intima

may'

occur resulting in

phagocytOSis of the lipid tiill'ld fomatim of foam eells.

Arteriosclerosis in Animals

The very widespread occurrence of arteriosolerosis

:J.r;

its various

forms in man obviously dictates the need for model l'3ystems in laboratory
animals which simulate the variot1s sspects of the pathologic processes which
occur in hUll'Ans.

tions a)
and b)

Research a_long these 11.1")e8 h8S taken t\IO principal direc-

Study of naturally

aCCllITine

lesions in various species of

an~JIla1s

Induction of arteriosclerosis ill various species by' che.:nical,

physical, hormonal and dietary processes.
Study" of naturall,y ocourring lesims has been qui to extensively

puraued.

Species Vtlrying from the aardvark to the wallaby have assiduously

been dissected end degree of arteriosclerotic involvement has been correlated
with what is know of the living habits of the particular group_

Fran these

studies recently reviewed by Lindsay and Cheikoff (1963) certain generalizations have come forth.

It appears that most speCies of mammals studied

exhibit naturallT occurring arteriosclerotic lesions.

This group includes:

Marsupials such a.s kangaroos. bandicoots, dasyures, wallabies;
as lemurs, macaques, baboons, chimpanzees, gorillas;
mice, squirrels, guinea pigs;

eo.rotesJ

Felida.~

~odents

Primates such

such as rats,

Carnivores such as dogs, wolves, foxes,

such as danestic eatsj

Lagomorpha such as rabbits, hares,

8
etc.

Among bird. naturalJ,y occurring arteriosclerosis has been found in

chickens.. pigeons, ducks" geese, swan., etc.
In most species of 1I8-.1 S and birds arteriosclerosis seems to be
initiated by' degeneration of certain components of the vascular wall.

If

lipids appear during the course of the development of the arteriosclerotic
lesims, this appearance seems to be a secondary phenomenCll (Lindsay &.
Chaikoff, 1961).

The site of lesions varies with species studied.

example in rats and cows the lesions involve

p~

the intima.

dog and cat both intimal and medial involvement may occur together.

For
In the
According

to Fox (1911), natural:b" occurring lesions in the rabbit are moat prominent
in the thoracic aorta where they appear as elevated intimal granulations or
large flat plaques.

Lindsay and Chaitoff {1963}, are of the opinion that the

naturall¥ occurring lesima in the rabbit are slml1ar to lesions in the human.
Duff and Ritchie (19,7) have described. three types of lesions in aortas of
rabbits.

Ck>.e COD.s1ated of focal accumulatim of poll'morphonuclear leucocytes

in the intima and media.

A seccmd type involved. medial degeneration, a

process related to aging, which in advanced o&ses had. converted the aorta to
a vide calcific tube with irregular fusiform dilatations.

The intima vu

thickened by' fibroblutic proliferation and the elastic laminae and muscularis
zone of the media were destroyed or disorganized by' var.r1ng num.bers of mononuclear cells that rarel¥ contained Sudan IV staining droplets.
an

unCClllDlOn,

The third was

naturally' occurring lesion consisting of clumps of mononuclear

cells immediatell' under the endothelium.

According to Linds..., and Chaikoff

(1961), in moat species of animals, demonstrable lipid 1I8terial cannot be
found in the earl¥ degenerative lesions and in earq arteriosclerotic plaques.
Moreover :in moat species :in which lipid material is found in fibrous intimal

plaques, its presetlceis restricted mainlir to larger and presumabll' older
mature plaques, usuall3' in the deepest segments adjacent to or in the media.
These authors state "It must be emphasized that lD'llike the arteriosclerotic
lasien in man, most later arteriosclerotic plaques in animals do not usuall1'
ccntain large amounts of lipid".

They also state that in a number ol species

of animals medial disease overshadows intimal fibrosis and thickening.
Extensive calcification of degenerating elastic tissue and the appearance ot
increased amounts ot mucoid ground substance suggested to Lindsay and Chaikotr

(1963), that the medial lesion ma-Y be basicall3' similar to that of the intima.
Bragdon (1952, 1954) has reported that fatty streakB fOUl'ld in arterial tissue

ot young children and adolescents are also present

in the young rabbit,

suggesting another s:1.milarity between the human and rabbit forms of the
arteriosclerotic process.

Exper1m.entallyr induced lesions

~

animals have been induced by

dietary- as well as chemical, physical and horMonal means.

Anits~ (1933)

produced "atherosclerosis" in the rabbit by feeding a diet supple1l1ented by
addition of cholesterol. .Among the advantages of' this procedure is the tact
that lesions are produced in a relativeq short time and the ease of handling
the rabbit in the laboratOl"1'.

Hartroft and Tbomas (1963) indicate that the

pathology produced in the rabbit by this Ileans differs from the lesions
produced in man in that the foam cell is the most praninent companent of the
lesion, the ucend.1ng aorta is more severe1ir involved than the abdominal, and
the lesials almost never proceed to ulceration, calcification and thrombosis.
Another disadvantage of the procedure according to these authors 1s the
observation that the rabbit is bjr nature a strict vegetarian with a serum
cholesterol level much lower than that of man, while the levels of cholesterol

:lD

associated with lesions in the rabbit are far in excess of those ueualJ,y seen
in man.

Bass et al. (1960)have reported induction of arteriosolerosis in

rabbits bY' feeding them excessive amounts or irradiated ergosterol.

Lesions

induced were characterized by" bone resorption and by' abnormal deposition of
calcium salts in various tissues.
of the aortic arch.

~~ith

Calcium appeared first in the inner media

time the calcific deposits spread

proceeded along the abdaninal aorta and its branches.

m depth

and

The principal changes

which these investigators reported, appeared in the internal elastic membrane
and the media, while the fibroblastic intimal proliferation reactions and

vascularized stramal resorption of the media. were the principal manUestations of repair.
Tsaltas (1962) has reported induction of arteriosclerosis in the
rabbit by mjeotion of papain.

'lhase lesions were reported to include the

development of raised white circumscribed plaques in the arch and descending
portions of the aorta and its maj or branches.

The lesi008 according to

Tsaltu u8ual.l.y involved the subintimal port.."lms of the media, but some
extend8li through the entire wall.

Elastica was fragmented and the lesions

contained an abundant deposition of PAS (Periodic Acid Schif'f) positive
material and calcium.

Ccnnective tissue proliferation and oartilagenous and

osseous metaplasia were also observed.
Katz and Pick (l961) have produced atherosclerosis in the ohicken
by' addition of cholesterol to their regular diet.

These lesions reportedlJ'

on rare oocasion mq ulcerate or caloif'y, but according to Hartroft and

Thomas (1963), differ from human lesicns in that calcification and ulceration

occurs far less often than in human lesions.

11

The rat has also been employed in the study of arteriosclerotic
lesions. v.Jissler et ale (19,4) and Fillios et ale (1956) have reported aortic
lesions follOWing addition of cholesterol, bile salts and thiouracil to a
semi-S)"llthetic diet.

Wexler et ale (1960) produced aortic lesioos in the rat

by repeated administration of large amounts of ACTH.

This group haa also

reported occurrence of aortic lesions in females which had been repeatedlT
bred.

Cholesterol supplementation and thiouracil added to the normal diet bas

been reported by' Steiner and Kendall (1946)
dogs.

to produce atheroscleros18 in

Cbolesterol feeding in pigems (Lofland 1961) also results in atheroma

fomatim.
:§pinephrine Induced Medial Arteriopat& (he of the key findings in
this area was the report by JUklllcich aDd Oester (19,0) that medial

a~al

sclerosis, origina.lly reported by' Josue (1903) to follow inj ectim of large
intravenous doses of epinephrine, could be greatly augmented in both severity
and incidence by concaaitant subcutaneous adm1nistratioo of thyroxine. Subsequent stUdies from this same laboratory. rOester (19,9); Friedman, Oester and
Davis (19,,>. Oester, Davis and Friedman (19,,>; and Roszkowski and Oester

(1956)] have described several drugs whicb appear to be of protective value
in the epinephrine-thyroxine reg1Dlen.
Friedman" Oester and Davia (19,,) reported that although both
epinephrine and norepinephrine were capable of producing medial sclerosis
when administered alone or in combination with thyroxine the extent of damage
produced. by' epinephrine and epinephrine-thyroxine regimen produced not onl;r a
greater :incidence but also a greater severity of the lesions.

Oester, Davis

and F'riedman (19,,) reported that wben intravenous adm1nistratim of a
Cholesterol suspen8im was added to the epinephrine-tby'roxine regimen,

12

int1mal sclerosis associated with proli:t'eration and foam cell formation
resulted,

medial damage on the other hand was similar to that observed when

animals were subjected to only an epinephrine-thy'roxine regimen.

Davis,

Oester and Friedman (19,,) reported that ATP (subcutaneous) was able to
decrease the severity and incidence of epinephrine-thyroxine induced medial
damage.

}-!ore recently O'Sullivan (1962) has reported that phentolamine

(Regit1ne) a.dnrlJlistered prophylacticallT

<Xl

a subacute basis was able to

reduce both the severity and incidence of medial damage,
(Diben~e)

phen~benzamine

under s:i,mjlar conditims appeared relativel1' ineffective.

Iproniazid (Marsalid) at low doses, was found to significant:q decrease the
incidence and severity of medial damage produced by injections of epinephrine
not accompanied by tb)"rOJdne administration.

Higher doees of iproniazid

<Xl

the other hand appeared to intensity incidence and severJ.:ty of' these lesions.
Ccnclusioos drawn from. O'Sullivan's stu.c:\r were that 1)

the

protection afforded by iproniazid was a consequence of its hypotensive action,
2)

the "vell defined and clear cut" protective action of phentolamine was a

consequence of its hypotensive and adrenergic blocking action, and)

the

rather poor protection afforded by pbenoqbensamina (Dibensyline) was
ascribed to the lack of marked hypotensiva action apart from the 1nhibiticm
of the epinephrine induced pressor etfect.

O'Sullivan has ascribed the effect

ot thyroxine in increasing severity ot incidence and severity of epinephrine
induced medial damage to an increase in resting blood pressure as well as to
a potentiation of' the pressor response following intravenous epinephrine.
S1milarl\y, O'Sullivan (1962) has ascribed the protective effect of ATP to the
hypotensive action of this drug and to a reduction of cardiac rate following
epinephrine.

His

statement "that the primary' infiuence in the development

of epinephrine 1nduced scleroa18 of the rabbit aorta is the increase in intra-

lum:1nal pressure and stroke volume consequent to the administration of
epinephrine- supports the omtention that the medial sclerotic effectl of
epinephrine and drugs either augmenting or protecting againlt medial Iclerolil
are a consequenoe of their cardiovascular and prelsor effects.
Waters (1954) and Waters and de 5uto-Nagy (1950) as well al Taylor

(1954) have also supported the ccntenticn that one of the prinoipal factors
in producticn of atherolclerol18 may be the injury of the arterial wall by

hypertentian or acute rises in arterial intraluminal presnre.
A relat10nlhip between medial arteriolc1erolu and atherolc1erOlis
has been suggested by Conltantinides et al. (1958).

They found in a chance

observaticn that the aortas of scme rabbits that developed accidental renal
damage while being fed a high cholesterol diet exhibited patchy medial
necroau associated with an unusualq severe degree of intimal atheroscler08ia
SUbsequentq Cmstant1n1des et al. subj ected rabbite to a thyraxineepinephrine regim.,. similar to that used by Oester at al. (1955).

Rabbits

were given epinephrine 1ntr&Venous~ at a dose of 50/Ig. for a period
of ten dqs.

Durlng the last five da.vs of the treatment period t.hyrox1ne at

a dose of 1 mg./kg. was administered suboutaneousq..
these animals were given a
weeks and then sacrificed.

~

en

oholesterol,

Atter a four day period

5. cottonseed oil diet for three

autopsy it was found that cholesterol fed

controls which had not. been nbjected to the epinephrine-th1rox1ne regaen
did not show &'nT evidence of atherosclerosis, while the incidence ot
atherosclerosis was

8~

in the epinepbrine-tllTroxine animals.

Aortic

cholesterol cmcentration in the epinephrine-thyroxine pretreated animals
was six times higher than in cholesterol ted controls.

Microsoopio

III

exandnation of the aortae disclosed that for the ioost part atherOOlatous
plaques were found over'4ring areas of medial necrosis.

Although the period

of oholesterol feeding was ml¥ three weeks, the thiclmess of
atherOOlGEl was of a magnitude

ObS6l"'7ed

eight week cholesterol feeding.

ma.ny'

of the

only in animals subj ected to at least an

Constantinides et ale (1960) have cmcluded

that prior medial injury greatl,v increases the atherogenic response of the

aortic intima toward hypercholesterolemia and atheroma formation.
Constantinides and his associates emphasize that these findings are

of great significance since they describe a mechanism whereqy atherosclerosis
can develop in the absence of conspicuous or prolonged blood lipid elevation.
They also help expla:tn t,he pathOletu"sie of some lipid-poor atheromatous

plaques in humans which have been desoribed as l'funderla1d by foci of medial

elastio destruotion."
These findings gain a particular importanoe in that numerous agents
such as

!om (adrenocorticotropic h01'l1.6ne), uneaturated fatty acid deficiency,

infectioll, etc., have been shown to produce medial necrosis in mammalian
arteries.

Thus Constantinides and his associates view medial injury' as a

-final cammon

pathw~

through which a multitude of stresses might sensitize

the intima to blood lipids and thus promote atherogenesis even in the presence

of onlr slight and transitor.y hypercholesterolemia."
Workers in the field have been aware of the possibility of medial
damage cmtri'buting to atheroma formation.

However, the absence of medial

damage underl¥1ng intimal atheromas has in many instances tended to negate
such a conclusion.

Constantinidea et ale (1960) feel tha.t one explanation of

these fuu:1:tngs may be in a greater potential
compared with other aortic strata.

ror

medial repair to occur as

Another significant factor according to

1

this group is that m some of their experimmts they found that in later stage
medial lesions can break down complete4r, fusing '11th the overl¥ing intimal
plaques.

In this way subatheromatous calcium deposits may become "intra-

atheromatous" •

Thus a lesion which began as an uncalcified atheroma resting

on partl;r necrotic calcified media ma,y end as a calcified atheroma resting on
an apparently- nonnal media.

Perhaps of importance is the observation that

some of the lesions produced by Ccnstantinides, which were pretiominentl;r
fibrous and l1pid-poor, are more similar to the human atheromatous lesions
than the tightly- packed plaques

characteristical~

produced by high lipid di

in the absence of medial injury.

Submicroscopic

!!pect~

The use of electrarunbroscopy as well as

density gradient centri.f.Ugation procedurev has ccntributed cOIl.siderabl,y to our
understanding of the relationship of cellular 'ultrastructure and function.
Siekevitz (19,8) has attempted to draw together some of the information which
has been made available in recent Tears to formulate a "working ccnceptl! of
cellular organization which although hypothetical 1n SOUle respects provides a
profile which assists in the Unification of various isolated concepts of
cellular ultrastructure.

According to Siekevitz one of the structures whose

functional relationShip to the cell is not too well understood is the endoplasmic reticulum which is believed to consist of a system of lumina limited
by a membrane approximateJ.y-

75 f thick. These lumina take the form. of canals,

vesicles and cisternae within the cell.

'.lhase spa.ees

~ppear

tobs :inter-

connected and form a "continuum" which permeates the cytoplasm. of nearl;y all
cells.

'!he endoplasndc reticulum fragments on homogenization forming the so

called microsomal fraction.

According to Siekevitz a common f1nding in

electron photCD1orographs is a generous concentratioo. of pinocytotiC vesicles

tiith wM.ch they coalesce on contact.

Thus Siekevitz views the pinocytotic

vesicle as a possible means by which extracellular matter may be tFansported

to the endoplasiuc reticulum.
The nucleuo appears to be bounded by two concentric 1ll6mbi"Mes..

em.

olose examinatiort the :inner ona of the two mermranes curvu back to merge with
t.he outer membrane at the edges

nucleus.

ot the pores which have been described in the

The outer membrane'. origin according to Siekerltz is in the endo-

plasmic reticulum..

In a further exposition of these concepts he postulates

the occurrence of enzymes such as hexokinase along the wall of the endoplasmic
retieul.um.
Rhodin (1962) has :indicated that rough-sur.faced endoplasmic retic-

ulum is extremaJv scaroe in the intestinal smooth muscle but quite abundant
in vascular

lJU8Cle

cells.

Be turther states "the function of the rough

surfaoed endoplasmic retioulum and the ribosomes is related to protein
synthesiS wi thin a cell.

In cells wi. th a high rate of protein synthesis these

cell constituents are quite abmdant."
Subsequent to the oharacterizaticn ot the mi toohondria as the

prinoipal site

or

oxidative phospbOl"",flation ,considerable research effort haa

been expended to elucidate the morpholog.r of this structure and to relate
structure to :!'unction..

It is generall¥ accepted that mitochondrial particlea

are bounded bjr two membranee, the ou.ter ot wh1ch forms the outer ahell, while
the inner evaginatea taming protrusions into the l1.lltlA!m

ca~led

crista,

(Lehnmier 1961 a).
La~n1nger

(1961 b) has indicated that the enzymes of respiration

and coupled phosphorylat1on are more or less firmly' imbedd0d in or on the
mitochor.tdrial membranee, and that the cristae are the site of these eo.zymatic

17
activities.

His group has fragmtllnted tnitoohondria and found that sizing of

the particles by differential centrifugat1.on produces particles which appear
to be relatively constant in regard to content per milligram. of protein
nitrogen, of cytochrome oxidase, beta hydroxy tutyric dehy-drogenasG, suecin...
Gxidase

L'td

ATLase regardless 01 particle size.

theM findings suggest to

Lehninger that the membranes are made llP of large numbers of recurring

structural unit. each of which may oontain a complete usembq of respiratory
carriers present in a fixed ratio.

He fllrther indicatea that an individual

liver mitochcndrion mq contain between fiVE! and ten thousand ot these
respirntol"1' .....bUes.

Although a oomplete apprec1ation of the various functions of
mitochondria has not been attained, Lebninger i.l1dicates that \-hese particles
possess three rather cM89icuoua properties nameq 1) eatalTai. of respiration and energy eoupl1ng 2)

occurrence of reversible swelling and contrac-

tion lGa.ding to water movements which are geared. to respira.tion and 3)

ion

transport aleo geand. to tho rospirato17 chdn.

Recent evidence accumulated in a number of laboratories suggests
that the swelling and contraction of the mitochondria !lIJJ1' be an eJC;Pression of
reSpiI'4to17 modulation of these particles.

This swelling and contraction in

tum may be a renecticn of mechano-cbem1.cal ohanges of the reapirato17 and

coupling ens.ymes. analogous to the mechano-ebemioal activities of the
aetom.yosin oomplex.
Perhaps ooe of the most useful pharmacological tools available for
the study

Qr

m1 tochondrial function is thyroxine.

It baa been well known tor

many years that thyroxine pretreatment ot animals increased respiration of
tissue slioes fr(D various organs.

Hoch and Lipman (19;4) reperted that a

18
Ca1s1atent decrease 1n the

p/o

ratio could be obta1ned in isolated liver

ndtochondr:ta tollow1ng tlvToxine addition i f the mitochondria were preincubated

with tb7ro:d.ne prior to addition o£ substrate.

.labi and Abelin (195)

that 11vor llI1tocbondria fran thyrotOJd.c rats exhibited

to spontaneous 8IfelJ.ing in vitro.

3n

reportal

incret;.sed tendency

Sub.equentli" D.emperer (19$$) found an

increase in water ccntent in t,hyra:dne treated mitochondria.

rap~' ~

al.

(19,,) reported that ~OJdne added in vitro enhances the nel11ng ot XCl
suspended normal rat liver IIdtochonclria.

F rem the pnteed1n, d18C\UJ8ion it 18 apparent that prev1oual¥ held
opinims :regarding the cause of al"teriosc1erosia are undergo1:rl.g considerable

revision"

In the put" r'JIllT authorities in thi8 tield have held that athero-

8c1eros1l:: is the cons8quenne of a single partieular predispOSing tactor. Hore
recentl¥ Keys (l963) ad :'ltalllel' (1962). have suggested that atherosolerosis

is due to a multiplicity of causes.

Atheroacleroais has been locked upan

pr1marilT as a lesion of tb,e intimal layer ot the art.erial wall.

As II ems...

quellee of the studies of Hus (l96O, 1962), Constantinides (19$8) and others it
i8 becOBl1ng increalingll' ev-ident that

les:i;.(ma

of the medial

la¥e.r of anen.

JUT pla¥ an important role in the toraUan of 1nt1mal lesions.

Epinephr::lne

induced. arteriopathT, in the rabbit, appear. to be an excellent model system
in 1fh1oh 1881ems of the lHd1a 1ItI1' be nudied. (Oester 19S9).

Beoause of the

possible relevance ot epinephrine induced aed14llesions to human atherosclerosis 1t. is iqlo.rtant that the mechanism or aechani$lla by which these
lesiCllS

are produced be

1'l.014e

tu.lJ¥ understood.
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Chapter

n

Statement of Problem
As a consequence of the increasing appreciation of the role of
medial dIt.mage as a predisposing factor in arteriosclerosis,

cCllfd<~ere.ble

speculation bas centered around factors whioh may precipitate or cause this
type of pathology.

O'Sullivan (l962) and Lorensen (19$9, 1961

A.

it) ~'We

interpreted medial arter1opatl\Y induced by epinephrine in the rabbit as a
resultant of the pressor effects of this drug.

This poait1en has beal

chal.1enged by MUch and Loxterman (l964) who ha.... suggested that "ep:1nephrine

:induces

II

defect in the biochemical a:r'Oh1teeture of the &l'1;er1a1 wall which

renders it susceptible to degenerative change. tf
ExaminatiQl of llte:rature in this field nggested that a better
appreciatiCll of the importance Cif possible etiological faotors might be gained

in studies which s1mulated the experimental conditions \D'1der which medial
arter10patq 18 produced in the rabbit.

In this regard it was felt that

central to the study of possible etiological factors was a studT of the
pressor effects of epinephrine, norepinephrine, and sclerosis antagonists in
both the normal and tbyroxlne pretreated rabbit where blood pressure was

monitored in an unanesthetized sn1mal. Consideration of the varioua drug
interactions suggested that results of blood pressure detarminat1cns in the

unanesthetized. rabbit would. give

SCB8

indication as to whether results

prerlousq reported by other investigators might bean. be explained on the
buis of pressor effects of epinephrine or whether the nature of drug interscticns:is such as to suggest that observed results might be explained

basis of a biochemical theory.

CIl

In the event that pressor data did not

eupport either of these hl'Potheses a third poasibil1t7 might be l1kel,,..

thtlt
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na.mel3', that epinephrine arteriopath;r is a coo.sequence ot a biochEmical detect
induced in the arterial wall which exerts a permissive actioo. on the induction
ot les1ms by pureq hydrostatic tOl"Ces.
Because of the paucitl' of literature data

(Il

subacute M.ochamical

effects of epinephrine and tbTroxine in the rabbit aorta it was felt that
exam1nat:lon

or

some of the tissue cmstituents would provide infoI'll<.'l.t.:ion

pertinent to the present. study.

Therefore, a subsequent phase of this

::L:vestigation included stud.;r of subacute eftects of epinephrine <.n various
parameters such as aortic lactic acid, gqcogen, glucose lactic dehyd.rogenase,
in animals subjected to the two week tn,rox::t.ne-epinephrine regmen described

b.Y Oester at

~

(1954, 19$$).

L1m1tatiar.1 of these b10chemicaletudies suggested that experiments
in which the eftects of both epinephrine and thyrcx1ne ou carboh;ydrate metab-

olism and protein synthesis in the isolated aorta might provide more meaningi"J.l information.
The very rapid gl'C'7lth ot radioisotope methodclogy in recent years
suggl3sted that this discipline could be used to particular advantage to

elucidate and characterize both normallletabolism in the rabbit aorta as well
as to provide additional clarification regarding cellular effects of the
sclerogenic regimen.
In atDnIJI&ry this problem entailed an evaluation of pressor effects
of ep1neph."""ine in conjunct1<m with various sclerogenic regimens as well as
with agents reported to protect against epinephrine induced sclerosis.

A

second phase ot this problem inclllded a survey' of several possible bioehemical
etfects whicb Ldght contribute evid810e supporting a biochemical basis of
ep1nephrine induced medial arteriopath1".
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Chapter III
Mater1a1a and Methods
Phase I
Hew Zealand white rabbits, obtained fran a local source, weighing

two to tour kilograms were used throughout.

Since previous studies by' Oester

et ale (19,,) tailed to establish a sex dependent relatiemship, animals ot
both sexes were used in accordance with the procedures al.ready described
(o.c.).

In all acute e:xperlments animals were weighed previous to AnT exper-

imental procedure.

In sub-acute experimenta, during wh1ch animals were

treated tor period.

or toumen dq., dail,y record ot

dosage adjusted accord1ngll'.
diet of Purina Rabbit Chow.

body weight was kept and

Animala were housed in steel cages and ted a

The quarters were well ventilated and room.

temperature was kept at a relativell' constant leTel throughout the experi....
mental period.

In acute experim.cts deaigned to determine eftects ot epinephrine
and ita antagonist8 em blood presaure, the rabbits were weighed, anesthetized
with chlorotorm, and irsobUized on an an1mal re.8training board.

Subsequentl,y

an incision was made in the inguinal region and the temoral artery bared by'
careful blunt dissection.

A pol,yethylene cannula (PE 90) tilled with heparin

dissolved in noru.l saline waa inserted. approx1matel,y six inchee into the
vessel so that the open lumen was located in the Ilidthoracic region ot the
aorta.

Pilot experilllents disclosed that in the weight range used, this

procedure 1nvariabl,y placed the open end ot the cannula in the mid thoracic
aorta.

Atter insertion the external end ot the cannula was plugged with a

small. piece of wire and then heat-sealed to provide double protection against

leakage_

The incisiem site was then closed with cotton sutures, the catheter
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taped to the inner aspect of the thigh, and the animal was allowed to recover
from anesthesia.

Righting reflex

us~

reappeared within fifteen minutes.

In earl,y experiments blockade of the cannula within
initial cannulation caused loss of

JJtany

preparations.

24 hours after

Since no detectable

differences in response to epinephrine were observed in animals prepared the
previous dq, as compared with animals used two hours after surgery', all
subsequent blood. pressure experiments were carried out in animals appraximatel,y two hours after cannulation.
Subsequent to recover,r trom anesthesia animals were placed on the
animal restraining board and the cannula connected to a blunted 19 gauge
needle attached to a Statham P23A pressure transducer.
Polygraph was employed to record blood l'!'essure.
Po~graph

A Model 5 Grass

Prior to use the Grass

was balanced and calibrated in accordance with manufacturers

operation manual.
Intravenous adm1nistratiCll of epinephrine and norepinephrine was
accomplished by means of a constant infusion pump calibrated to deliver a
constant volume of 0.6 cc per :3 minutes.

Adjustment of total dose to 50~/Jtg.

was made by varying the concentration of drug.

Thus whUe the volume

remained constant (0.8 m1.) in all cases the epinephrine or norepinephrine was
administered at a rate of !fIJ't/Kg./:3 minutes.
made via the marginal ear vein.

AJ.l intravenous injections were

Both the rou:i;.e

fAnu

period of administration.

conforaed to that previously used by Oester (1955) and O'Sullivan (].962).
PreparatiCl1 of Drugs

Unless otherwise specified all drugs were administered

in a vehicle of sterile-non-pyrogenic saline.

!f,~i"Phr~,!1

'WU p:t'e~ tr(t.r.1 Or,rstall.i:le :l-epinephrine baa. (Carncagies

.:..i$1t:l~ed, Lot

13lfYt). stock lolut1orL COrlta.it'led 1 • •/TAl. of saline, eolub41 ';-

by .nddit.1C11l ot one :a1t.d.ln of' OOllCetrtrated llCl, l'fJagct grade, per twenty' mla.

TiJe atock 8olut1Gl i.laa stor&;l in

ux:1.da.'1.t.

&

1're.er at 00, arid t.ha:wod prior

to t:1nal 1.10 dUut,1m. III seweral aperimdrlta asp Nt....lee S't.8ndard
r.;p:1nl99hl·1ne B1t.artr<.&W waa ad.;juateJ. to allcwo conoa,tintiou.
WSi"$

PrelI.or l"e:IP«....

ldenUeal to tb.oee el.1.;)1ted by the epmepbr1ne 'bue obtained frGn

e&rnog1ee .Liuu.:ted.
~~!I
~

~ (stnthroU, ~ ~, LGI; 1612>1.) va \iHd
St,ook

aolu.tJ.c8

'W6Ir8 p~

of tohy,vGld.no w.. accaapl1all«t by ~

O.2S .../>al, vu

no:r.i in

.

Phal'tcilamne ut.b.ane&Ultate
W8'ft\

in awrU.e

.ol:u~

f'roeaaeIt .\

~, C1ba, Lot.

1.t.-3a36)

dUsolved (10 ... /riJ..) in ~le 8al1ne illl8cl1atel¥ beton u..

?henS!l~in. ~. (D~liDJt, SIa1t.h, nine
Lot,

~ll;d l;jMti«l

addit.* of o.laN NtiIOH. 'l'he

0'7.
u.s.p. CResiUnJ"'"

fA;

salin..

Iu-DZ) VM d1iJ8oJ.ved ." • O<lloct.n.\1tm of 2

pnar t.o

_./raJ..

ed i'reuch,

11\ aiierile aline

\'1M.

~!!9! (HaN1l14R, v,ynala ll
et.er'J.a uHno at. a

Botfillan La Roche, Lot 132) WM diaaol:f8d iD

CQ'i.OCt.rat1ol1 \)f

S .../mJ..

The pH was adjut,ecl t.o

IIPprald.at.el.r $.0 1d.th

11»

~Q81ne 1'~

Soct1wa lal'\ ... obtained trGII liltl"1t..1Gfaal D1oo.b.eII-

1la<il ~wn. pnor to \188.

1oal8 C.,. (Lot;,64l9). • ......t..1'a\1f;4 of lDO ..../ml. (in at.eJ."'Jle
ci1aUJlecl _&tar) • •

~

~.9'NP2:.W.~ B1~

~ . . dieeol"f1d

:t--.iiat,eq PI'iOl" to ue.

(W:1ntbrop CbeI11ula1 Corp. iA IH2.$1UB).

at • OU'lCflnvat.icft o£ 300 . . . (baee)/1Il.

The

in ateril.e
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saline prior to use.
The injectiCll protoool inoluded coo.trol administration ot ep:inephr.in
or norepinephrine during a three minute period followed by a fifteen ndnute
period during whioh return toward normal was allowed to ocour unless otherwise

When ATP,

5Pecified.

phen~berzamine

or phentolamine were administered

proph7lactioally, the subcutaneous administration of these drugs was performed

30 minutes before ohallenge with epinephrine.
phen~benzamine

amine and

In the case of both phentol-

a f'ractim of the total dose vas also administered

intraTenous13 (marginal ear vein) five minutes before the epinephrine
challenge.

Thyrcx:1ne pretreatment eonsisted of subcutaneous inj ection of'

0.1 mg.!tg. of' th;rroxine daiq in accordance with the procedure employed by
O'Sullivan.
The follOWing doses of drugs employed were used l

Epinephrine,

50'O/kg. (as base>; Norepinephrine, ,Ol/kg. (as baseh Thyroxine,O.l _./kg.;
ATP,200 mgs./q.; Phentolamine (Regit1ne~

5 mg./kg.

s.o. and

5 mg./kg.

i.v.s

Pheno:x;ybenzamine (Dibenzyl1ne), 2 mg./kg. s.c. and 1 rog./kg. i.V"i Iproniazid,

30 mg./'kg. s.c. 24 brs. before experiment and then

8.0.

again ';0 min. before

epinephrine challenge, five minutes prior to epinephrine challenge an
additional

15

mg./kg. Was

administered intravenousq.

Phase II

Drugs employed vere prepared and
Phase I.
stated.

administered as described :in

At least eight anj mal s were emplo,.fWt per group unless otherwise
The following determinations on aortic tissue were performed;

1)

Tissue gqcogal using the method of Se1fter at al. (1950).

2)

Tissue lactic acid using the method of Barker and SUlIII8rson (1941).
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.3)

Tissue inorganic phosphorus using the method of Fiske and Subbarow (l929).

4)

Gmcose using the glucose oxidase ll1ethod (Glucostat

:reagent~

Worthingtm

Biochemicals CO%l>., Freehcld, N.J.,).
(See appendix for descriptim of details of the procedures.)

No:naal unanesthetized animal8 received 50~/lCg. of epinephrine and
were sacrificed by separation of the cemcal vertebrae a.t two, three, four,
five, six and eight hours follOWing administration of the drug.

The chest

caTitT was opened and the aom rapidq removed. After wuh1ng and removal ot
the adventitia by stripping. two samples ot aortic tissue were excised and
weighed on a Mettler balance.

(he of the two samples was placed in 10% ltOll

and beated in boiling water tor a period of )0 minutes in preparatiCll for the

gl1'cogen anal¥sis.

The second piece was placed in cold TeA. and homogenized.

The latter tissue aupernatant was employed for phosphate and lactic acid
determinations.
Phase lIb

New Zealand rabbits as preriousl¥ described in Phase I were given
da1q treatment for a two week period as tollows.
Group 1.

Normal ccmtrola (1 cc/kg. i.v. saline).

2. Th,yroxine controla, 0.1 ag./kg. s.c.

3. Epinephrine 50'l/kg. of epinephrine (expressed as base) i.v. uin
Phase I.

4.

Epinephrine SOI/kg. (ct. Phase I) and tb7roxine 0.1 mg./kg. s.c.
On termination of the two week treatment period the animals were

sacrificed as in Phase IIa and the aorta d1vided into three secticns.

The

first two were processed as described in Phase IIa whUe the third section
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a~plo.red

for gluoose, laotic dehydrogenase and protein determinations.

d~drogenase

was determin&i

L~ accorda~ce

(1957) described. in detail in the appendix.

Lactio

with the procedure of Sobel et al.
Protein was determined in accord-

ance with the procedure of Gornill (1948j see appendix).

For purposes of

comparison, samples of thigh ntU.l3ale were also removed and treated as described
above.
Phase III
Rabbits were decapitated and the chest oavity rapidlv' opened.

The

aorta was removed b.1 rapid but oaretul disseotion, care being taken not to
exert 81lY' aignU'icant traction as the tissue was being removed.

The aorta was

then transferred to a petri dish containing either Krebs-Ringer phosphate or
Kreba-Ringer bicarbonate 'buffer at rocm. tel.a.perature. During the period of'
subsequent dissection performed so u to minimize trau.ma, the tissue was
continuou8~

mixture.

OJCnellated using either ~ ox;ygen or 9,% ox;ygen -

,% CO2

After the bulk of the adventitia and adherent fat was removed the

aorta waa sliced using a sharp scalpel into twelve

sections~

The first six

successive sactims of the first half were oOB1b1ned with corresponding
suocessiTe sections of the second porticn so that each sample contained one
piece from both the high and low thoracic aorta.

Pilot experiments indicated

that reproducibility- from eJq)eriment to experic'l',ent was greater if rOOl'fl
temperature butfer was used in preference to ioe-cold buffer which tended. to
produce erratic results. The paired sections were placed into a second d1ah
which also was axygenated. The samples were then removed to filter paper
moistened with buffer and ImT visiblT remaining bits of adventitia were

removed.

The tissue was then rapidq weighed on a torsim balance and

returned to the second petri dish awaiting completion of final cleaning and
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weighing of the ."t1re series of tissues.

Identity of tissues was maintained

by using a oompartmentalized tissue holder similar to those used in processing
tissues tor histological fixation.
Aortic tissue pairs WGl"e then transferred to disposable metabollS1ll
!'1asks (see appondix) and gassed for a. period of 10 minutes with shaking at

37°C. A mixture of 9$% ~ - S% (;~ was used in the cas. of Krebs-Ringer
bioarbonate butfer, while the X:Mbs-Ringer phosphate buffer was gassed with

loo,C oqgen.
Subsequentq they were recapped with serum stoppers j
beakers containing nuted filter paper wet with
the stopper.

lOB were suspended from

In all experiments radioaotive substrate was added before tissue

addition to tluk.
gassing.

4N

small plastic

In drug experimEmts, dru.gs were also added before tissue

CGrlcentratians used were as followsl

adenosine triphosphate 2 mg/ml

pbentolandne 0.1 mg/ml and phenOX)"benzamine 0.03 mg/ml.

Atter gassing was

c .....leted. epinephrine was added to appropriate samples.

The tlaaks containing

tilfsues were :incubated tor varying periods of time in a metabolio shaker at

80 strokes per minute using a

li inob

stroke.

TaDiperature was maintained at

37Oc. At conclusion of incubation period, experiments in whiob collection ot

C~ was deaired, incubation was terminated by the addition of 0.$ 111. of

4 N 1 2S<\.

The fluks were then shaken tor an additicmal 30 minute period,

at low speed in an Eberbach shaker to effect complete trapping of CO2 •

At

the end or. this period the exterior of the leOH beaker vas washed with

distilled water, (washings being returned to incubaticm nask) and the serum. cap
was then placed atop

III

counting vial containing 0., mI. of Hyaa1ne 10 X

(Packard Instl"Ullent Co.).
0.4 Ill. of

Once the serum cap was

final¥ sealed

in place

4 N2K SOu was added to the banging plastic beaker to e.fteet
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release of the

C~

trapped by the KOH.

The counting vial wu 8llbsequently

shaken for an additional period of twenty minutes to effect transfer of CO2
to the Hya.'1line in the bottom of the vial.

When the second shaldng was

completed. the serum cap was rEtTloved and 10 ml. of Bray's solution (1960; see
appendix) added..

A plastio cap was then affixed and the sample counted in a

Packard .3l4X liquid

8cintillat~.or..

original incubation

nuk

counter.

The aortic sample remaining in the

was t!'ansferred to a sample vial containing 10 ml.

of a 2,1 chloroform-methanol mixture and shaken for a period of six hours to
remove moisture and fat.

Subsequentl;y, the chloroform-methanol mixture was

decanted and the procedure repeated. with shald.ng for an additional 2 hours.
The aortic samples were then allowed to -dry- at room temperature for an
additional 2 hours and then weighed to detemine dried defatted weight.

It

was originally hoped to determine protein via the method of Gomall; however,
the addition of acid to release CO2 caused sufficient denaturation to D'.ake use

ot this procedure tor estimation ot protein nitrogen not feasible. The madium
cootaining flasks were capped. and stored at 00,.
ana~ical

until aubj ected to turther

proces8.

Procedures involved in

stu~

of incorpora"ion ot uniformly labelled

];ysin. C14 into protein were carried outin a manner sim:1lar to that described.
above, except that no attempt was made to collect

C~

and incubation was

terminated by removal fr<= medium and freezing of tissue rather than bT
addition ot acid.
The tissue was prepared for counting bY' the procedure de8cribed by

Farrese and Reddy' (196.3).

In brief, the aortic sections were added to an ice

cold hOlllogenizer and hcaogenized in

5.0

mls ot ice cold sallne.

During the

entire period. of hOllOgenizatiCll the tissue grinder was kept in an ice water
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bath.

The tissue debris was th81 removed by centrifugation and the super-

natant used tor preparation ot protein by addhlg 1 ml. of cold 2.,. TeA to a
1 m1. aliquot of the protein.

times with cold 5% TOA,

The resultant precipitate was then iiashed .3

extract~

twice with 5% TCA for

remove nucleic acids, and washed again with cold TCA.

1,

minutes at 90°C to

Subsequantl,y the

residue was washe:d twice with eth;yl acetate to remove lipids.

'Itte latter

procedUre appeared more dNlirable than the usual chloroform extraction since
it minimized flotation of protein particles.

Finall¥, the protein residue was

dried in a counting vial" 0., ml. of Byamine lOX added, and the sample
incubated for 18-20 hours at ,,'~c to effect digestion of the protein.

Onder

these conditions digestion of protein appeared complete and no discernable
yellowing of the Myamine was evident.
of

Br~ls

Upon CIlllp1etion of the digestion 10 mJ.s.

solution was ado.ed to the v1al and, the sample counted for a min1m.um

of ten minutes in a Packard .3l4I liquid 8cintUlatiCll counter.

In all cases sample counts were adjusted for instrument ef'ficienc,y

based

al

counting of a sealed c14 reference standard.

Background averaged

approximateq 80 CPM and sample oounts in each experiment were corrected for
backgrc~d.

Correct1C1l for quenching was performed in accordance with the

channels ratio method described by Baillie (196.3) and Bush (l963).

Briefliy,

the method involved preparation of several triplicate samples ccmtaining
var;r1ng cQlcentrations of Hy'udne lOX a strongq quenching substance.

Counts

recorded in the "AU channel 'Were divided by counts recorded in the "Bit channel;

thtis.ra. t.:Lti, was plotted against countiLg effioiency corrected for instrument
efficiency_
CO\'!nts

This linear plot was then used to correct samples for loss of

due to qnen.cl:d.ne_

'!bus all radioisotope data was converted fran CPM (oounts per

minute) to DPM (disintegrations per minute).

Chapter IV

Reeu.lta

Szetol1c Blood Pre.sure Effects of Pl"etreatamt by Yarioua druga on the
pressor response to epinephrine in the unanesthetized rabbit are Ulu.trated
in figures 1 - 9.
Tablea 1 - 3.

Speoific data obtained in these experiments are listed in

Figure 1 illn.trates the pre-infusion oontrol 18ft1 of systol1o

pressure and peak q.tolio response following epinephrine.

Peak systolic

1eYel attained following norepinephrine is denoted by horisontall7 hatched
bars.

The peak systolio level (Fig. 1) attained follCMing epinephrine, was

not signitieantll' different from that following norepinephrine, (p}O.OS~ ).
SimiJar1;y there

11M

pressure produced

no .1gniticant difference between net increase :in 878tol1o

'tf' these two drugs (Fig. 2). '!'he percentage increase in

s;yatol1o pressure (Fig. 3) fol.lGw1ng norepinephrine . . smaller than that
fol.l.cad.ng epinfllhrine (p • 0.09).

'l'hil differenoe was in part a reflection

of the higher centrol q8tol1c level of the norepinephrine group.

Pretreatment of rabbits for two weeka with thy'roxine produced a
rise in thepre-1nfuslGl leYel of BT8tolic pressure (Fig. 1) J howenr, both
the net and percentage inor...e in S;Y8tolio pressure following epinephrine
were significantly lower in magnitude than in ullne treated oontrols
[p values o.o~' and 0.001 reapect1ve].;y (aee F1gs. 1 ... .3 and Tables la and

]h]

The peak 87etolic level in thia group following epinepbrine was not 81gn1t1-

cantl,y different than that ob.81'T8d 1r.t saUne cantrole (P)O.OS~·).
Iprcn1uid, at a dose reported l:f' O'Sul11van (1962) to aupant
epinephrine arteriopathy lowered the peak pressor level attained follOWing
epinephrine ad1I1nlatratian.

The net .,..tolio pressure increase in lprCll1azid

pretreated. an:laala was not 81gn1tloantlT different trom that observed in
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saUne pretreated controls (Fig. 2), while the percentage increase vu lower
(Fig. 3).

Administration of ATP caused a decrease in control qstolic pressure

to approxtmateJ,' SS. of that observed in saline pretreated controls (Fig. 1).
'!he peak systolic leYel following epinephrine was signilicantl¥ lover than
that obsel"f'ed in controls) hGNever, the net increase did not differ s1gnifi-

cantl3' from that in cmtrola. The percentage increase increase in ..,.sto1:1c
pressure vas .1gni:tican1;q higher then that observed in cmtrols and 1s in
part a reflection of lawer ccmtrol levels of ..,..1;0110 pressure in the ATP

pretreated an1mal.a.
with

t~e

Adm:1nistratica of ATl to animal. pretreated for two weeks

(Tabla 1) did decrease the control ayatolic pressure, however,

the peak lVstolic pressure leYel following epinephrine was almost identical to
that obael"f'ed in thyroxine pretreated controls.

Both the net and percentage

increase in systolic pressure following epinephrine were higher in animal.s
which were pretreated with both AfP and

~e

as compared with anilllala

receiving thyroxine alone (Table 1).

According to O'Su11:1van (1962) phentolamine (Regitine) is

lIlore

potent in inh1b1ting epinephrine arteriopatby than phenoxybensamine

(D1benS7line) • In the present studies phentolaine pretreatment resulted in
a lower preinfusim systolic level than did pretreatmmt with phenQlll'bellzamine

(Fig. 1).

Similar13 the peak 8,1stolic level following epinephrine infusion

was lower in the phentolamine pretreated animals than in the pbenCXXJ'bfmzam1ne

pretreated animals [p 0.0, (Table la, b)].

The net and percentage increase

in aynolic pressure response to epinephrine, although higher in the

phentolwne pretreated group was not statistioalJiy different tran that
obt&1ned in phema.ybensamine pretreated animals.

2

Diutolic Bloccl Pressure changes followmg pretreatment bl' var10ua drugs and
following infusions of epinephrine and norepinepbrin.e are silustrated in
Figs. 4 - 6.

Data corresponding to these values 1s l1sted in Table 2a and b.

Fr1edman et al. (195$a and b) reported that norepinephrine adrrdnistered on a

subacute basis produced an incidence and severity of medial arteriopatby
s1gnif1can.tq lower than that produced by' epinephrine administered under
identical conditions. In the present stud.)" the peak diastolic pressure level
(Fig. 4) was not s1gniticantl,y different following infusion of these two drug
S1m1larl,y both the net and percentage increase in diastolio pressure following
in£usion of these two drugs was quite similar with no statisticalq significant d1.tference being observed (Figs. $, 6 and Tables 24, b).

Subacute

thyroxine pretreatment produced an increase in preinfusian level of diastolic
pressure and also increased the rise :in diastolic pressure £ollow1ng

epinephrine 1ntuaicm as compared't!ltb saline pretreated controls (Fig.
Iproniazid at a dose reported 1V O'Sullivan (l962) to

4).

augDl81t

epinephrine arteriopat1\Y lowered the preintuai01l level ot the diastolic
pressure. However, neither the peak d1a.atolic level attained after epinephrine infusion nor the net increase d1.f'£ered significantl,y with that obsened
in saline treated controls (Figs.

4, S and

Tables 2a, b).

The percentage

increase in dill8tolic pressure following epinephrine was higher than that.
observed in salin·e controls (Fig. 6) and was significant at the S% level
(Tables 2a, b).
A'fP pret.reatment decreased the preintusion diastolic pressure more
than pretreatment with

&n)"

of' the drugs studied (Fig. 4).

The net increase

with epinephrine was almost identical to that observed in sa11ne contro18.
The percentage increase in diastolic pressure tollo1d.n& epinephrine exceeded.

that produced

~

any ot the drugs studied.

This observation is in part a

reflect1C1l ot the rather low pre-infusion diastolic pressure level.
traU.Orl.

ot

A.dm1nis-

A1.P to animals pretreated tor two weeks with thyrmdne signlfi-

cantlv decreased the pre-in!u.sion diastolic level [p 0.001 (Tables 2a, b)]
cOlJlPared with an1mals pretreated with tterraxine alane.

a8

The net and. percentag

increase in diastolic pressure following epinephrine infusion did not however
8ignif1cant~ differ from that observed in the t}~e

and

ccntrols (Figs. S. 6

Tables 2a, b).
Phantolam1ne decreased the pre-infusion diastolio pressure to a

greater extent than did phmaq-benzam.1ne (fig.

4).

However;l following

epinephrine intusion the peak diastolic response net increase as well as
percentage increase in diaatol1c pressure did not differ signiticantJ..y betweEIIl
the two groupe (!l'ables

2.,

b).

Mean Blood Pressure changes in general paralleled effects observed in analTSi

of systolic and diastolic pressure changes.

As in the case of diastolic and

systolic pressure the peak mean pres8Ure and net increase in mean pressure v
not s1gni.ficantq different f'oUowing epinephrine or norepinephrine infusions
(rig. 7 and 8).

As in the case of diastolic pressure the percentage increase

in mean blood. pressure did not cU,fter

signii'icant~

when these two drugs were

compared (Fig. 9 arJ.d Tables la, b).
Tb;yrox1ne pretreatment increased both the pre-1nru.sion mean blood.

pressure (;'ig. 7) and the peak mean blood pressure following epinephrine
inf'uaion as oClll>ared with saline controls, while the net and percentage
increase in mean blood pressure following epinephrine was not sicniticantll'
di.fterent from that observed. in saline controls (Figs. 8, 9 and Tables la, b)
This parallels results obtained in anal¥s18 of diastolic pressure changes.
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Ipraliazidpretreatment employed a total dose of 7'5 • •/Kg. which
apprmdmates that reported by Spector et al. (1960) to produce almost total
il".hib1t1cn

or

Ilonam:ine oxidase in the rabbit.

'this dose of iproniazid reduced

pre-infusion mean blood presSt'tre and deel'''e8.sed somewhat the peak mean pressure
following epinephrine infusion.

sign1f'icant (Tables 3a, b).
pressure following

'!he latter difference was not statistically

Both net and percentage increases in mean blood

ep1nap~..rine

were not sigT!.ifieantl.y different frem. values

obtained in sal1ne cmtrole.
AfP" as in the cue of syst.ollc and diastolic pressure, lowered mean

'!'he rlse following epinephrine 1ntusiCll achieved a

arterial blood pressure.

peak level lower than that in saline contro18, however, the net increase in
mean presS'Ul'tt was almost identical to that observed. in oontrols" while the

percentage increase was s1gn1t1cantll' higher (Figs. 8, 9 and Tables 3a, b).
Biochemical studies In several pilot experiments the t1m.e course

0

effects of epinephrine on blood constituents snoh as glucose, lactic acid and
inorganic phosphate were studied.

In general, results were in accordance wi

data available on other species in that blood glucose and lactic &eM rose in

compariscn "ith controls.

'!'hese data suggested that changes in blood conatit

uent, plateaued appradaatell' two to three hours folloldng intravenous epine-

phrine ad.min1atraticn.

The rabbit aorta contributes Ql:q. about 1 gram to the

total body mus in a 2 1dl.o rabbit.

Thus possible lIletabolic changes in aorti

tissue vould not be expected to be revealed by a study ot blood constituents.
Tb,retore tissue analysis of the aorta itself

1mS

underta.ken. Pilot experi-

ments vere conducted 1n vh1ch aortic levels of g:qcogen, lactic acid and ph
phate wer. determined following intravenOltS infusiCll of. epinephrine.

Slight

decreases in aortic phosphate and lactic aoid levels, reaoh1ng minima at 2_

hours respectiveq were observed.
cal.l¥ 81gnU'1cant.

Epinephrine did oause a decrease in both aortic and

ske13tal muscle g~ogen (Fig.
decreased. appro:.d.rnatel¥

1,

40%, as

In skeletal muecle obta:1n.ed
approx1matel¥

Theae changes were not howeweJ', statist1-

frOU1

and Table

4).

In the aorta, gl,ycogen levels

oOMPared wi tIl controls

(p

0.0)% (Table

4)].

the inner aspect of the thigh, ill-cogan fell

66% as compared with c<I'ltrols (p 0.00]$). Th18 depletion was

maximal at four

hOl.U'8

Since

atter epinephrine adaini.tratian.

~.

has .. known glycogen. depleting effect it was felt

that determination of the effect of the sclerogenic regimen with appropriate
controls might suggest further routes of exploration.

Thus four groups of

eight an1mals each were treated dail3 for fourteen da;ya as tollOW's.
Group 1.

Saline controls

JDg./kg.

2.

'lbI'roxine 0.1

).

Epinephrme

sor/kg.

4.

Epinephrine

50t/kg. i.v. + 'lb,yroxine 0.1 mg./kg. s.o.

8.C.

i.v.

The results obtained are illustrated :1n Fig8. 10 - 14.
Subaoute administration of thyrQIC1ue or ep:S.nepb:r1ne alone did not
aign1!'1cantq decrease aonic gl¥cogenj
dru&8

however when ad1A1n1atration of both

was combined. a signifioantl¥ lower level of aortic glyoogen wu observed.

(Fig. 10). a:qcogen in skeletal muscle was somewhat higher in the tlwrOldne

treated. rabbits and lower in th¥'roxine + epinephrine t.reated animals as
compared with controls.

Theae difference. were not statisticall.Y a1&nUicant

(Table S).

Aortic iltlCose levels (Fig. 11) were elevated in rabbits which
received either epinephrine or epinephrine plns tJwrox1ne (P .. 0.01$).
An:hruals receiving t.l\Yroxine alone had aortic g::ucose l.evels not sign1ficantq

;6
dii'f'enmt .t'rca those fcrund in saline treated cmtrola. Although ekeletal
muacJ.e glacoae wu elevated in all three experimental groups thia 1ncreue was
signifioant

.ll'

in the group recei'rlng epinephr1ne alone (Table 6).

Aortic lactio acid, in the tby"roxine and epinephrine treated groups
(Fig. 12), was similar 1n magnitude to that found in saline oontrols.

The

elevatim in aortic lactio acid seen in the epinephrine plus tl",raxine treated
group wu not statisticallT signifi.aant (Table

7). No signiticant changes in

ebletallulscle lactic acid were observed in anT of the e:xper:im.ental groups.

Similarlv no significant changes in lactic

d~enaae

levels were ohesrvee!

either in aorta or skeleta.l muscle (Table 8). Aortic pb08';.b.ate was lower in
tll1roxine and thyroxine plas epinephrine groups, while in animals receiving
epinephrine alo.ne levels were almost identical to those oOseNed in aaline

oontrola (Table 9).
Ph..e In
At thie phue of the investigat.iOllB i t was telt that u.e of'

isotopical.ly labelled auostratea; might provide evidenoe ot a

DlOre

direct

nature as to the effects of both thTroxine and epinephrine on aortio tie.ue.
A number of pilot experiments were oonduoted in an effort to aoh1sve ntis-

factory consistency of resu.lts. Data obtained on clb.~ producticn and
standard error were oCl'l81atent with those reported b.r Muloahy and Winegrad
(l963).

Kinetic stUdies were oonducted en both normal and

pretreated animals.

tliO

week thyroxine

The•• data are illutrat.ed. in Fig•• 16 and 17.

In all

radio1aotope e;xperiaents counts per Jid.:nute were corrected to disintegration.
per Ddnute (DPM) by ue

ot the cllaunels ratio method and ext.r&.polated from a
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In aortic samples incubat.ed for a period of tvo hours in KrebsRinger phoaphat.e butfer (D!) epintl.Phrine appeared t.o :increase

c1402 proc1uc-

tiGll by apprax1Jaatel,y thirty p.:reent (Figs. 18, 21 and Table 10).

When either

ATP or phentol..ud.ne .ere added to the aortic s&1llPlea OCl'lta1n:lng epinephrine a
decrease in C~ below control le9'el8 vas noted. lihCl phanax;ybanzlJldne wu
added hOlfenr, c14~ productiCID did not dUfer sipit1cantll' tr_ control
Talu.es.
If _ the other hand aortic samples were incubated in a Xrebs-R1n&er
bicarb...te buffer CGDtaining

O.Sj(MIlIl..

of unlabelled. glucose, a lIUoh ure

s1gn1t1cant ri,e in c~ productiCl'l vu noted in the epinephr1D.e tlJeated
,~ta

(Figs. 19, 22 and Table ll).

Norepinephrine under equivalent cCIlditiCl'ls

tailed to produce a significant increa,. in c~~ productiGD (Table 13).

AfP,

although antagaoizing the st1llu1 ant etfect. of epinephrine, did not appear to
caUie u great an inhibition as either phentolud.ne or phmoq-benzud.ne. When
aortic ,ample, vere incubated vith glucose 1-014 some increase vas obeel"Yed
ewer that with the label in the 6 posit1al (Figs. 19 and 22).

Epinephrine did

not hOll...er appear to cause as great an etfect on c~ productiCll with the
label in the

11 position as compared nth C-6 labelled glueo...

When aortic samples from an1mal8 pretreated s.c. with 0.1

1lI./ke.

of

tbJroxlne tor two weeks, were incubatacl :In ICRB bu.tter u described above an
almost two fold incr.... in

c~ prot:lucticn vas noted (Figs. 20, 23

and.

Table 12). Additim of epinephrine caused an additicnal two-fold :incre..e :in

c~ producticn. this st1malation of c~ prOductiOll wu not blocked

by A'tP,

but wu inhibited by both phmtolamine and phClOll:1'benzam1ne the t01'll81" producing a greater 1nhibition.

Incubation of aortic tissue tram thyroxine

pretreated an1mal.ll with glucoae labelled in the III poeiticm resulted in an

8

almost sixfold increase in

cl40z produotim as compared with CI1.lI' about a two

fold increase observed. in normal animal. (Figs. 20, 23).

Addition of epine-

phrine to aortic samples from thyroid an1m.als incubated with glucose 1-014
evoked little incr...e in c~ productim (Figs. 20 and 23).

Neither A'I'P nor

phenQ1C'3"benzamine appeared to signUicantl1' affect c~ production from glucos
1...c14 while some inhibition was noted in samples treated with phentolaDdne.
Thus in all. three series of experLaents epinephrine produced a

significant :!nerease in c14~ produetiCll vb_ eompared witil control samples
alao incubated with glucose 6-014•

Bot,h

phento1aaine and phenox;ybenzamine

were found to inhibit c~ productiCll, phentolamine being the more active of
the two drugs 1n this respect.

AfT! appeare4 to ettect some inhibition

or the

stimulant etfeat or epinephrine in the 'reba-Ringer phosphate (m) and ltreb.Ringer bicarbonate (DB) butf81's but onll' weakl¥ so in the DB + ,lue...
seri... Whm.AfP was added to aortic aamplea from. TbTrox1ne pretreated
an1.mala little or no effect was noted.
Incubation of aortio tisne with ll's1ne U.t. 014 resulted 1n
incorporatim of this amino acid into prote1n.
incorporation (r1&se

Epinephrine inhibited thia

24, 2S). For aumple at me hour the rate of incorpora-

tion of labelled q8111e into protein in tissUe treated with epinephrine waa

CIrlll' about a

third of that observed in untreated oontrola (Fig.

24 and

Table 14). Aortic ti88ue from animala pretreated with th.yraxjne for two weeb
exhibited an incorporatim rate less than forty percent of that observed in
normal. controla. Aa in the case of the noral animals, thl'roid pretreated
aortas appeared senaitive to the i1Ihibitol')" effect of epinephrine on l¥sine
incorporati<m into protein.

ATP appeared to antagonise this 1nhibitioo,

bringing the incorporation rate up to almost the control level in the 'tbyroid
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pretreated group.

Neither phentolamine nor phenoqbenzamine appeared to

effect any significant reversal of epinephrine inhibit10n of lTsine

incorporation into protein (Fig. 2> and Table

14).

L.O

<a>

Acute Itt.eta Of lpiD8phr1ne (I) or IoreplDf1J)lu1.on syatolle Bl.OO4
Pre88'Ul'e in the ~thetiHd Ia~i t PoUow1na Pretrat.nt by Varloue Druaa.
SYSTOLIC B.P.

~\

Control
After Epi.

50t/Kg.
50~/Kg.

C _ E

Fig. 2

80

NE

T - E

I - E

ATP-E

R - E

•
ii

D - E

NET INCREASE IN B.P.
After Epi.

50~/Kg.

After NE

50t/Kg.

~

•
•

INCREASE IN B.P.

After EPi.50.r/Kg.
After NE

501/KgJII

'1'be :tol.l.cN1ns doe_ were ..,lOJ8d: (I) epinephrine 50 /kg., <a) norep1neIq.j (t) tbyrox1De 0.1 ma./q.714 4qa a.o.; (I) lpron1u14 3Onta~
a.c. 2"- bra. before and apia 30 iii_tee before ep1Depbr1ne toll.oweCl by
15 q./ka. i.v_J (A.,) adeDoeSM tripllo8phate 200 .".7q. a.o.; (ft)
fheDtol_- BeptiM 5 mg./kg. a.c . . . 5 q./ka.1.v.J (D) plleD~ne
(D1'tJerlJ)"l:LDe) 2 q./q. 1.91. U4 1 q./ka. 1.v. All sllbfttaneou <a.c.)
iDJeoUons ve.re _i.iatend 30 II1JNtetJ ,rior to eplnephr1De ohal.lenae unless
othe1'V1M .taw. All latl'llYeDOWJ (1.v.) 4rus pretrea1;.lleD1f va.a "'1ntaterel
, IliDUtee betOft ep1lMr.Phr1ae chaUeaae. I1pt oi.ls .... per iJ'OUP uoept
aorep1Mphr1De srouP eoaalaW of HftB 8121_1. ad. tb;trox1M 81"OUP caulateet
of JdJ:Ie ul.1 a. "Ccmt1'Ol" reren to ayatoUc blood preuure nbaequeJlt to
drug pretnBtaent but pnor to B or B.
pbr1M 50
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Acute Effects of Epinephrine E or ~orepinephrlne HE on Diastolic B
Pressure in the Unanesthetized Rabbit Following Pretreatment by Various Drugs.
Fig.

4

j

T'lIASTOLIC B.~.

Control
After Epi. ~uY/K
After NE sut/Kg.55

'lET PfCfI. TN T'lIAsT. B.l'.

After Eol.
After !olE

111_

.

;?

12"

I

~

INCH. TN T")·A~'t'. B.~.
•

After 1";pl.
After 'r'~

==

The follOWing doses 'Were employed: (E) epinephrine 50 /kg.: (NE) norepinephrine 50 /kg.; (T) thyroxine 0.1 mg./kg./14 days s. c.; (I) iproniazid
30 mg./kg. s.c. 24 hrs. befo~ and again 30 minutes before epinephrine
followed by l5mg./kg. i.v.; (ATP) adenosine triphosphate 200 mg./kg. s.c.;
(It) phentolamine (.Regitine) 5 mg./kg. s.c. and 5 mg./kg. i.v.; (D) phenoxybenzamine (Dibenzyline) 2 mg./kg. i.v. and 1 mg./kg. 1.v. All Subcutaneous
(s.c.) injections were administered 30 minutes ~rior to epinephrine challenge
unless otherwise stated. All intravenous (i.v.) drug pretreatment was
administered 5 minutes betore epinephrine challenge. Eight animals used
per group except norepinephrine group consisted of' seven animals and thyroxine
group consisted of nine animal s. "Control It refers to diastolic blood
pressure follOWing drug pretreatment but prior to E or HE infusion.

Acute Bf'tecta Of Epinephriae (I) or hrep1nephr1ne (D) on Mean Blood prea.ure
in the lJDaDea~izedBabb1t PoUowtq pretreatment b1' VariOUS Drugs.
MEAN B.P.
IbO

ControL
Atter Epi.
After NE

'0"

140

c -E

NE

T - E

I

-:c

A'I'P-E

R-E

D-E

NET INCR. :',IEAN B.P.

After Ep1.
After NE

_=_-

---

C-E

T

I

ATP

R

D

% INCR. MEAN B.P.
Atter Epi • •
Atter HE 55

C-E

NE

T-E

I

ATP

R

D

!he tolJ.ovina 4os.. were eaploye4l (.) 9iaephrine 50 /kg.; (_) DO:repinephr1De 50 /kg.; (tt) tb,;yrax1De 0.1 q./kg_/14 .sa,. a.c., (I):i,Pl'OIl1aZid 30 mg.l..
a .c. 24 hl'II. 'betON aDd ap.1Jl 30 llirmtea before epi~ toU0ve4 by
15 mg./q.1.v.J (A'1'.f) a4en0aiM tn,holIpbate 200 mg./kg.a.c.; (a) pbentolam.i
(Ieg1tine) 5 "./"a.a.c. ud 'mg./kg.l.v.; (D) p~u1ne (D1benzy11ne)
2 mg./ke- i.v. u4 1 mg./ka.i.v, All aubcutaneous (a.o.) inject10as vere
"2niatered. 30 1I1mttea prior to ep1aeplu1.ne cbaUeuae UDl.eaa otherwiae
stated.. AU 1Dtra'VOO\lS (i.v.) 4ru& pretreat1DeD:t vaa adain1ate:rect 5 minutes
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Am_la were tnate! as follows: (e) COIltrola 1 al./kg. aal1ne l.v.; (Be)
ep1rlepbr1ae 50 /kg. i.v.; (m) ttqrox1ne 0.1 rag./kg. a.c.J (Bt-!') epiaphria
an« tb;Jrox1De as aboYe. Period of 4rug administration _s 2 weeks.
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Incubation medium oonsisted of IRP - Krebs-Ringer Phosphate Burrer. Each
tissue sauple was inoubated with 0.5 microcurie. of glucose-6-C14• Samples
were shaken in a .etabol1o shaker at 80 strokes/minute. Te.mperature 3700.
Incubation of aortic samples was stopped at 1, 2 and 3 hours by add1ticn of
liN sulfurl.o acid. ~e pretreated animals received 0.1 mg./kg. of this
drug aubcutaneousl¥ for 14 day'S. (Epi) epinephrine o.5r/ml. of medium added
at beginning of incubation.
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Incubation medium consisted of DB - KJ:oebs-R1nger Bicarbonate bu:t1er. Each
tissue sample was incubated With 0.5 microcurie of u.l .. lysine cL4 • Drug
concentrations used: (a) epinephrine 0.5 /ml..; (ATP) adenOSine triphosphate
2 mg./ml..; (a) phentolamine (Rag:ltine) 0.1 mg./ml..; (D) pheno;vbenzamine
(D:lbenzyline) 0.03 mg./ml..; Incubation time was 2 hours at 3t'C., 80 strokes
per minute. Thyroxine pretreatment 0.1 mg./kg. subcutaneously tor 14 days.
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.........--· _ _ _ .,............,.. _ _ '".. ~ _ _ ·~ ... ~ ... _

_u""· ......._

1.3.

'i--.----·--·-,t---~-·:

I------...-...,:;.-·----"----·---·T·~·-'

I.S.

,.-.---.----..-

.---..~.-------I.--'"--.-~ -.----.~---- . ----

1 ft ~
t.:I
0.01
I
I.S.
II
.
-'''-'--'-''-'--'''l-''---~-'-~'-'''-'--'"'-''''l-~-''''·--·-..··-1'--·------·-··--·-·--·
1 ?8 6
'1.8.
.
I.S.
'
l\f .. s.
~.~."
"'---'~-'1-'
1 .... T i
(0.00l
i
(0.001
.
o. m.
---·--·t--··--..
-·~-~- --··-,-·----I
1 .. 8
(0.001
l { 0.001
i
(0.001

-_..

l ... S

I

. t--------..-.. .-.----------f------'1-------..
.
. ---"1 _. ·. ·--··-·-·4--->·~-·-·.. ·---------·--··..---·-..··

o.as

'

1.8.

I

1 .. 8.

.

1.8.

-_..-. ., . .---1---- _._._--t---_. --·-·-·----1'·"··. -. -...------.. -..---.--,..
... 8

1.1.

--------'-_.._-i

ft.s.

l

~

'fable

Levels of

G~ogen ~

It.

Aorta and Skeletal Muscle Followmg

Acute I.V. Epinephrine (5b¥l~g.) in
n

24

hr. tasted Rabbits.

*

Skeletal 11usole

Aorta
,

1.

SaUna Controls

9

67 t 6.6

2.

2 brs. atter !\pinephrine

8

,1 %

.3. 4 hre. after lpinephr1ne

8

40 t 3.46

4. 8

e

,9 i 6.. 6

hrlll.. a.t'tGr Epinephrine

, Values

*

Source

W.S. •

or

122 t 18.1 !lga. %

rags. •

'.9

_
7.1
----_.-

83 t 21.3

ft

It

41t

ft

•

71 t 1,.8

"

I
I

N.S.

1vs2

N.S.

1va)

O.os

.001

1"4

N.S..

.~

skeletal muscle was inner aspect of the thigh.
A

p value> 0.0,(,%).

tt

Skeletal lIuscle

Aorta

Not Sign.i..f1eant or

..

S7
Table !)

Effect of Subacute (2 't'ft.) Administration
or F,pinephrine and Epinephrma + Thyroxine
(XI

Tissue rAVels of Gl3"cogen in the Rabbit

n
1. Saline Cootrols (I. V.) 1 cc/l.g.

2.

~.

(••c.) 0.1 mg/(g.

8

Aorta

Skeletal t-tuscle*

lOh. t 11.2 • •_ 182. t 41.6 mgs ••

8

Sk. t 13.6

11

253. , 20.9

3. Ep:mephrine (1.1'.) SO,//r.&.

8

108. t 11.4

11

172. t 34.3

..

h.

6

It

138. i 2).8

fl

F.p1nephrine (1.1'.)
+ 'I'h1roxine (s.c.)

SOI/Ia.
o. . mgfrg.

~9.

P Values

*

Souroe

I .. V. ..

or

i

4.S6
-

Aorta

--I-"

_...

Skeletal Muscle

1"2

i.8.

N.B.

1 va.3

N.S.

N.3.

ln4

.. 01

~l.S.

skeletal muscle

~ae ~~er

aspect o! thigh.

1ntraV8llGUII

s.c. .. subeutaneoua
N.S ... Not Significant or p value

> O.O~(5%).

tt

Effect of Subacute ( ! wk9.) Ad!dn1.8tretim of

Epinepbr1ne and

~...nephr!ne

+ ~1zl.

CI'!

T1eaue

Gl.ucose in Ute Rabbit

- - - - - - - - - - '----;---r-----

II

,--,--.------

2. 'l'by:rald.ne Ca.o,) 0.1 rogJr.g.
''''"-'''''''<~-'''''-'''~"'~'''~''''- ~~'''~_''V_'

'<

I

t ".-t-

__~. _~lin.~~tr~~~~.~~.) 1 e~/Kg·1
. ..-, ...•.-

--.----:-----.---.~---.---.'--

ft

""_--..w .... " ""........--,-.--~.""~~~>"'~", "-,...·..,·""'.. -·~-<~,~-"' ........

8

OJ.....

.70.1 ~ 1.81

"
..

4. Epinephrine (i.v.) SOllrfI 8 i
..
f---.+-~~.! _q~~.!"8!&~_ ..!~~!} ). ..L ....._-- "," ......

I

I

I
PValuea

1136.
to 20.9 ..
1
' - '11S6.

t 16.1

..

t-··_-_··_-_·-_·· ..
t~
_9.~_,.~_
n

.. _: .

•

I

I I Aorta
! Skeletal MuNle
-.. ,-1---,.
---.-.. "· -· . ·~---r
·"W·~
_ _ _ ._·...'

i
1 w 2
I I
N.8.
I
l----.-------.-.. - .. --.- --t-_·_-..,..·_--_ . """""----.-",. _-",, .. -----.. -; -

L

Ske1etsJ. lfu80l.e

I

j

~

:

.~~--,---.---."".-.-.--41.1:' 3.'1.~." 91.8 t 11~S~~;;

I 8 ~.9 !t 6.96
---·1-· .'V_--,.~",
i 8 I 97.0 't.1O.6

3. F.plnephr1ne (i.v.) SOtlKa.
-.---.------..
- ..
.--.-J--.-~-_4

I

A ......

1 va 3

I

L ______,.__~~_~._I

·w .......

- -. ...

.5.
. . . . . . . . ,.H-...............
"... --.. .

t ____~O~__~__I_-..-_--.--.. -~OS-..------

L__ . . . _·~~

1.8. • Not SignIficant or P TIthe> o.Os (~).

. ~~~..._. . ._.

"lable 7

Etteot

or Subacute

(2 wk.) Adtdnistrat10n

or

tp1nept!:rizle ane !ptrlephrine ,.. 'ltqrc:ad.r.e aa.

Tissue Lactic Acid in the Habbit
,«'... ... .•-.......'.' ", .... ,•.• '-..... "-t" ..... ,

"" .

~

.. -

-j-'In!
. '--1" '-_Aorte
. _-'- .. _,., ."..,.,-,.

r' ...,......

.

,~".,

I Skeletal }iucle

-." '-'"., ,., ".- -. ..'"
._4...~_~.~~.. (1~".) ~CO~.~~~:~.=.~.4~.:C+!,3~•. :.2~~IIp'~

, ...., •. - .., « - , -

2.

.

,-._ • • . -

.•" •• _- " ..'.'" ...,-_. -"",,""

~~~ .~•• o.)

" " - ' .",.__ .

0.1

,-"

•••

mg/Ia~-l 6

r-~-- -.-!~~.~~~Y.) SO ('c--.
4.

!P;:::=: ~!:::~ ~~.

1---""--""" ,.""",., "'.--'-' "~.' "-"'"

•

i

,-,~-,

7~38 .-~--v.~ t 2~~4 . ~_~_

59.2. t

I a i ~~ : ~.~_ .. I 408. ! 3~1'~_~~_

I 8 ! 14.1 t '.9
i 377. :t 25.2
.-J-- -----,-~,---- ---..'...",_. +,-,-,-.---,-~--. ,,-""'I,
I
I Aorta
I Skelet.al iiucle
It

~'~-'-'-"-'.'-'-'- ""----'

,

i

l;~";'T'
,

It

l

N.S.

I,

11 .5.

""'-"""--1----"""'---'--""''''

'~"-'-'- • .f

I

l
I.S.
!
ll.S.
r-'----"--·'l-;;-4r-·~;:·~~'··"-"'--··--r"·'" "·N.~'. " ' ----,------"'- ...",,-.."- .,--,.",'•.... ..._' ... _-'._-,,,,.,,.....,.-.'... ,. ......". ,1

VIJ

"

"
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Table 80

Effect

or S-ubac:ute

(2 t;1k.) Admird.stratiro

and Epint"Jp}J,rine .. Thyroxine

or Epinephrine

Aortio IDR (tactic

CL.

Dehydrogenase) Levels tn the ltabb1t

n

tJn'.ts/lOO mg. yet Wt.

Units/mg. Prot-air,

1. Sa.l1De Ccot.rol8 (Lv.)
1 cc/Eg.

8

7." : 0.880

1.46 .t 0.17$

2. 'l'hrr:7le (s.e.)

8

5(2) t

O.~4

O.98¢ 0.126

). ~in~e (i.v.)

8

6.80

~

0.70)

1.29 :

4.

8

6.80 t 0.0211

o. 1II&I'1aO~g.

Itdnephrine (1.v.)
;0 fF4,.
+ 'nl11'OX1ne (s.c.)
0.1 'If'{!/r.g ..

1.3' t 0.l.l9

PValues
1

2

N.S.

N.B.

1"f'53

N.S.

li.S.

4

11.8.

N.S.

1

i.v.

lilt

VB

VI'S

1ntra:venoUi

a.c. • subcutaneoue
5.S ... !tot Significant or p value

> O.os (S%).

.02It6
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Table ,

:ll'l the Rabbit

1. Saline Contro18 (l.v.) 1 eo",.

--,

.----------

). Epinephrine (l.v.)

sortra.

14.6 t 0.87p.H/lIXJ

111".

8

----------1
1O.74t 1.>2
..

8.

14.1 t 1.41

a

10.9 t 0.16

..

---.------+----.~-----------------------

I1~I_P__v_ah--8~a----------~-----~
I
I
I

1 va 2

J.vs4

i.v.

1#

O.V)

I

intravenous

N.S. • Not S1a;a.1.fioant or p value )

O.os

(~).

,

tabla 10
In Vitro

c~ Proc1u.ct1al b.r .lort1e T1ana

lraa Gluoo8e-6-Cllt.

~. . PhoIIpbate
11

Butt..

~.Wetft.

~.DI7wt.
z
per hr.

z

per hr.

CCIlVola

14

20.28 ! t.ll

71.906 t 8.2

2. Epinephrine

14

28.1 t ).1

109.10 t 11.6

6

12.28 t 1.14

SS.8S

8

ll.19'& 1.)2

S:h9. t 1.2

8

18.21 t. 2.81

80.,.

~

3.

Ep1nephr1l1e + .lTP

4.
S.

Epinapbrlne + PheW_De

-

...,-"

Epinepbr!ne +

Phen~

--

'fable ot P Valuea
Group

CCIlCCltratiCil18

-

~

P Value

lvaS
4nS
)nS

liaIlIIl.

t 13.6

P Value

1n4

f'oll.ow1ng dra&

_______e_

Dry wt. Baa18

1 va 2

b

---

Wet ft. BUD

lva)
2va4
2vaS
2va)

phctolud.ne 0.1

- 3.87
~-

+

.OS

<.001
<.001

.01
.01
I.S.
B.S.
I.S.

•os
.os
I.S.

.oS

were emploTed 111 the incubat1cD medium Epinephrine O.SO/ml~

ad phenfDTbenumine 0.0) mgfml.

I.S. cienot_ lot S1p1t1cant or a "P. J.aorel greater than

.os

<.001
<.001

S%. (O.os)

R.S •

I.S.
I.S.

m

2 mg/ml

Table JJ.

In Vitro

C~

Productia1 by .lmic fta8\1.

Frca Gluc._ 6-014

Xreba-R1nger B10arbanate Bufter
Gluc08e Added

D~.Wetwt..
x
per hr.

n

D~

..
----------+-----+----1. Controls
8
2.146 1'. 0.)40
--1-------_..
2. Epinephrine
8
11.90 t 1.42
-.--------- ..
3. Epinephrine + m
8
4.730 to 0.SQ8
_.

--~-

=

-

o.~M/ml

,- -.

- - - - - . -..- -

..

of

me Drr W\..

x

per hr.

11.62

*' 1.110

~.-

46.77 t 6.S

-------+---.---t--------------I~

-

----.-~ .•

.

._-

;1=+

4. Epinephrine + PhenWlurine
-----,---,--...'_. ----S.

_._-

Ep1nephrin.e + Ph_aqben&aJD1ne
8
- - . - . - - '--.
P Taluea

1.8.S2

t l..6S

.- ..
t 0.174
0.64
'__1.072
.____
,.------1----- 4.268t._--

- '

_

-~.------.-----.,-

2.502 t. 0.217
9.397t. 0.924
---.
..----f---'-----,------·-----I'O"
vJ
wet. ft.. Bu1e
Dry ft. :SUa

--

-,---------

P ftlue

lft2

2ft)
2ft4
2ftS
4nS
1 va 4
1veS

(.001
<.001
(.001
(.001
(.001
(.001
B.8.

P value

1ft2
2 .... 3
2

--

V8

4

2'V115
4vsS
1 V8 4
1'9'85
.

_-

(.001
<.001
~.OOl

.001
(.001
<0.01

N.S •

!he tollow1ng drag CClDcentrationa were eap10red in the h1cubaUm medilDl1 lp1nephr1ne O.~~ml, .l1'P 2 mg/ml,
pbet.oludne 0.1 ic/ml, and phenCD:1'beDzaR:l n e 0.0) mg/m1.
'

N.S. denote. Not Significant or a "pit level greater than

SJ.

(O.os)

Tabl.e 12

In Vitro C~ Production by Aortic T'1.uue
(2 wk. ~e P:rRreated Animale)

01ucoee-6-C14

Ireb~er

o. ~ml

---_.

D~ agWet.wt.
x
per hr.

D

,"----.-

1. Controls
1---'

'-

,_

,----

3. Epinephrine + A'tP

-

DPK/lOQ JIg D17

x

lO3 per hr.

6.072 t 0.614

22.8S t 2.34

.._-,,-

8

ll.38 t 1.49

,-,

41.71 t 4.62

8

12.39

t 1.41

46.70t S.61

,-

-

-

4. Epinephrine + Phentol.am1ne

8

.3 .203 t 0 •.34S

S. Epinephrine + PbenCll:l'benzu1ne

8

6.091 t o. S1S

,,-"---

12.49 t 1.30

'--

-~--- 1 - - ' _ "

-

wt.

--,-

,--,,,,-,-

8

2. Epinephrine..

Bicarbcnate Bafter
of Glucose added

,._

24.34 .. 2.ll
.....' - , - ' " "

Table

or P valuea
1;;"2

Wet \1\. Baa1a

0.01

0.01

2va)

N.S.

H.S.

2'9'84

(0.001
0.01
0.01

(0.001
0.01
0.01

H.S.

<0.001

2 .... S
1 .... 4
1 .... S

" .... S

<0.001

!he foll.otdDg drug CClDCtI1tratiCll. were aployed in the incubatiCll medium Epinephrine
pheto1urf.e 0.1 muml 8'1d phenGll'benzam:Jne 0.03 mtt/BiJ..
'.rbtro:dne 0.1 wc/Ii; 1f&8 adDdDisterec:l aubcutan"'ll' each dq tor two weeks.
W.S. denotes Not Signllicant or a

Dry wt! B..~_

"p.

leYel greater 'thm S%. (O.os)

B.S.

o.Sr/ml,

'

A'l'P 2 'llig/ml,

61)
'fable 13

In Vitro e~ Production by Aortic 'f1aaue
From. Glucose-6-C14

Krebs-Ringer Bicarbonate Butter
Kreb....ain&er Bica-batate Butter +O.~ml.CIhooII
!

I

I' D~i:mgt\tlet
Wi;.
x
"'liel' 'im.

II.

-1,

-2.

C (IRB)

6
--'-----j----_.
__.
6

]£pi + (KRB)

3•. Bpi

+ ATP (DB)

-- I-

6

:t6-~
6

ATP (m)*

-6

-.-

6. Phmtolam1ne (DB)*
1.

Phcuq-benlludne (DB).

6

8.

Narep:l.nepbl"1n.

6

-.,-.--..

2.33
34.65 t ,.90
---1---------2).46* 0.63
9.26 * 0.86
_.
/'" ...
-

t--._._._-

-

~------.-

-_.
3.61 * 0.26
2.84 t 0.61

----.---Wet wt. Bui.

Group

lft3

11.36

--

* 1.S3

4.03].t 0.,8
6.86O't 1.19
12.86 t. 2.)
Dry

P Value

-.---.,~------ -.-~-

lft2

8.1331 1.04

*

P Valu••
....

~
..

2.49 0.1.&3
3.41 t 0.51

-

-

,..--- --

12.11

1.45 :t 0.11
--

t--_._.
----------~---.-

...

31.51 1 4.86

----,-...-.-- r-'--

-~

+

,._-.--n
-----~
4. e (IRB)*

,.

n.89 t 1.73

... --~-.~-..

~
x ' »fII{:.D1'7
___ 'llr____ Wt.

wt.

Bas18

P Value

~---.-

If.S.

If.S.

N.S.

I.S.

~--------- r--'

__ .-

2ft3

I.S.
----.

4ft5

J.S.

H.S.

4n6

Jt.S.(O.l)

O.OS

4 ... 7

I.S.

I.S.

4 .. 8

I.S.

N.S.

---

_.-

I.S.

r---'---'"

!he tollow1n~ ~ cC'llcen trationl were aplored in the incubation medium
Ep:lnepbl"1ne .S~ al, ATP 2
Phefttolaadn. 0.1 ma/ml and PbSlc.'Jq'bensuine
0.03 mgfml, lorepinepbr1ne O.S;/ml.

""'al,

N.S. denotes Not Signif1cant or a tiP" lsYel greater than

5%. (o.os)

Table 14
In Vitro

C~ Produeticm

by Aortic !ialUe

Ji'rool Gll1cose-l-C 14

Kreba-Ringer Bicarbona1ie Butter

+ O.S~K Glucose/al.

!n
2..

Epinephrine

*

a
a

1DN/100 JIg Wet wt.1 nPKlloo mg DIT Wt.
:'It

I
I

lOJ pt;r hr.

I

2'1.4 i 3.76

x'

10l per hr.

100.8 ill.)

~--------------------------+--+------------~------------~

m ..

).

Epinephrine +

4.

Epinephrine ... Phent.olamine

7.

Epinephrine

1--._-.... '-"-- •.. -.....•.••..

!8

*

2).0

18.0! 2.7.3

I

l6

"~r- _._.. _-.._-- -.,.. - - - - - - - . . .
,

t 2.42

I

86.9 i

8.6

66.l !.

1O.S

7.741 1.2,3
I )0.8 i 4.90
--.---.--L-.---------

._.- --.-.--.•.- .•..

P Vall1e.

I

Dry lit. Balis

Wet Wt. Balis

1..,.2

N.8.

I

I.S.

l

1 va )

w.S.

I

w.s.

t

1

h.

I.S.

S

W.S.

;

N.S.

0.001

I

0.001

.001

J

.001

!

V8

l ....

ln6
1ft7

J

I

N.S.

The fol.lo1d.ng dru& CCIlCttD.VaUcaa were .,loyed in the :LncubaUon medium
Epinephrine
lal, A'tP 2 mg/rel., phtotolaaiDe 0.1
and.

O.sr

phcO'q'benza1.ne 0.0)

*

ms/ml,

arlal.

Obtained from rabbits pretreated. With 0.1
K.S. denote. Jet S1gn.1t1cat

Or' •

mtVlc.

tb1'rax1ne

8.0.

P l.,el grea1ier than

for 2

S!l.

"ka.

(0.0,)

Table 1$
In V1\1"o Ip1ne U. 1.. clh InoorporatlC1b 1.i.-t.o prote1n by Aortic
T1saue trOlil Nomal and 2 Wk. ~. Pretreated Anima1a

DPH/lOO JIg. wet

n
,---~_, __ ~"'_,' __ ._~. _ _,___ ,,_,_~.. ,'~----"-'-""

..,-,--L---,..-_-

1. Normal Controla
\ 4.
-_._-_._-- _. __~______.w,·_._______·-1.--~ ....

!
4.!
..--..,,-, .-...... --1--. --'.",

'.~e Pretreated Controla* i,

3.
_..".~, _ _ _

, _ . _ " ,...., _ . . . . .

. . _ ,", .,......_~ . . . . . . _ " - _ .....,.. .....

~> ..

, _ ...... "

~"

_ _ _ _ _ ~. _ _ ......... _

".n ."' ....

_~._"

4. Ep:ineplU"1n....
.. _ _

~_,.

~
:;1*

----1--.-..

Epinephrine (Ncmaal Anhl&lJJ)

2.

------,..--"'-.-~.-- ~ .. ,,~-.--.-.-,...-

_ _ ••

~~~.

-'"v

"'4

_ . . . . . . __

'_'''~T

.'_

~

_~

~

___

~.,

_~""

. _ " ..

""'.< ...

~."

,.... -...... .....
~

~"

",~.".

"
Epinephri •n
+ ATP

12 .6S ! 1.67

,.. _-_ ...__ ..,",-, .. "",,,,, '.""., ,.' ,.

8 ,,

6
!","' ___ . _,,_.'
!i 8

.

32.72 t 4.1S

---.-'-·~--'-·---·-'-'-'----

ll.20St 2.$

"".,. ..........,.-~.,.,.,... ....1 .•. --.~~,-.,.-~ ..... ~ ...................... ---,----"'.--......,....y--,~·....-.~-"' __ ,.

j

1
~.,

,._

~~

<

j

.....

1.oS8t
-«'<.

•

,~~"'

._.,<

II

_~

7 • Lpineph~'ine + Pheno.qbenuraine i
... , ____

."~

.. "

~_,~.

__ ,

~

..

~.,

......... «..,""""'_,,,.,..- ........ '

....

_~

_,. . . .

,~.....

~

•

'-" .........~,~-.~

1.22
"'!""'

,e~,

"-'-'~

...
...

-,,".,,"'

q ,,'q.,..,...--.-

....

2.27

6.6Trt.'~.~. ,.

6:

f

".....

10.01

:-~~,~-~~~~~~~~~~-Ph;~~;,~ ,'-.J ~.~:.~·-r,.~.·
''-_ ... "". __ ,......... ""

wt.

x ].OJ per hr.
--~-,-- ..--.. - -- .. '"

.....

'~_h'

1.217* 1.14S
·0"

. . .•

, . . . ."

PValn.

1n2

0.01

i

--.~.--,. '-"--'----r--·--~--·-

1 va'

..

-,----~ -~-.'"'--"'.------

i

0.01

. .""'+... ---, . . -...... "'>~.---. . .

2 n.3 I 1.8.
---..__ . -_. , 4'-T---;~

,,--......... _. --'i'ft' i
"-"-"~"--".,

o~·ooi.**-

T-··~-~s

.. ,

>,

..'-.._.- .....1'.....'" '-"',,_ .. ,,-,.,
4 va S,

o.os**

- -..... -----~- .........., .... - ... -,.."j... ~,..,.---,,,---~- ,~.~

H

*

""" ..

I I.i.
' '".' -", ...._..... _- ..
4 .... 1 I I.e.
h .... 6

-'-"-'-~-"

••

-",'-"'~'"''''

i

,

'

Uainc paiNd dUferenc.. uthod

f1aaue obt.dned f'rcm _tala pretreated tor 2
0.1 mg./Ig. a.c. of 1.'hyrod.ne
.

ween with

!he foU.old.Dg drqa ccmoentrat1ona were eBlPloyed in the incubatlcn medium
o.S- llll, AT!' 2 rarlml, phentolaa1ne 0.1 ar/alt 8t1d
phcoq'bensudne 0.0) ";'IAl..
EpJ.nephr1ne

l~.S.

denotu Not 8igrlif1oant or a

"p"

leV'e1areater than

S_
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Chapter V
Discussim
Medial Sclerosis and Vasopressor Ph810mena
Several investigators have suggested that the medial sclerosis
following an epinephrine regimen 1s a consequence of the vasopressor eftects
of this drug (Lorenzen, 1961, Tqlor, 19S1u Waters and de Suto-Nagr, 19SOa;
and O'SulliT8ll, 1962). Although this positim is not without merit, it is
quest1mable whether such a narrow interpretatim is adequate to explain the
nrious observations made in this report and by other investigators.

The

presfllt studies en vasopressor and metabolic erfects of epinephrine and
thy'rox1ne suggest that a broader ..sessment or the role ot these two drugs in
medial sclerogenea1s might be more consistent with experimental data.
OUr own ..sessment or the vasopressor theory or m.ed1.al arterio-

sclerosi8 has b8fll conditimed by a paucity ot critical exaudnations ot the
vaaopressor relationships involved.
of epiJlepbr1ne t s preuor actian by

Qualitative mention or the potenttation
t~e

has been invoked by O'SUllivan

(l962), 1orenz81 (196l.a and b) and others as categorical evidence that

epinephrine induced medial sclerosis is primari4r a cmsequenoe of the press
aotims of this drug.

Sec~,

it was assumed that drugs which potentiate

this pressor .rrect will increase the incidence and swenty or the ar$erial
lesions.

Conversel1', it was assumed that drugs which interfere with the

pressor actions ot epinephrine will provide protection against arterial
lesiens (O'Sullivan, 1962; Waters and de Suto-Nagr, 19,Oa, and Lorenzen,

1961&, b, 1962a, b).
Examination or the preHl'lt data suggest that some discrepancies
exist between the ability of a drug to prevent rise in systolic or diastolic
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pressure in acute experiments and its ability to prevent epinephrine induced
medial sclerosis.

Pertinent to this observation is the data in Figs. 1 .. 9

and Tables 1 .. 3.

Thus iproniazid pretreatment at the· ·dose employed

decreases the net and percentage mcrease in systoliC pressure following
epinephrine but according to O'Sullivan (1962) on a subacute basis greatq

augments both the incidence and severity of epinephr:1ne induced lesions.
Ccnverse~

ATP which does not significantly- inhibit the net or percentage

increase in qstolic pressure caused by epinephrine infusion is perhaps ene

of the most effective agents known in preventing medial sclerosis inductien
by epinephrine (Davis et al. 19S5).

Phentolamine and phenax;ybenzam1ne

produced an inhibition of pressor response to epinephr1ne to an a.lm.ost equal
degree (Figs. 2, ), Tables la, b). Yet, according to O'Sullivan (1962), when
administered

prop~laoticall;r

on a subacute basis phenoJr1'benzamine is rather

ineffectual :in preventing epinephrine induced medial sclerosis while phentolamine shows good activity in this regard.

Norepinephrine, which in the normal

animal produces a slgn.if'icantl3' lower incidence of medial damage than
epinephrine, Friedman et &1. (19"a, b) produced net changes in systolic and
diastolic pressure which were sindlar to those obserV'ed with epinephrine
(Figs.

2, 4, Tables 1, 2).
Acute diastolic pressure data similarl3' do not appear to be f'ull¥

cCI'U.istent with a pressor theory'

or

medial sclerogenesis.

Iproniazid

pretreatment at a dose reported by O'Sullivan (1962) to 1l1tensify epinephrine
induced medial sclerosis did effect a net increase in diaotolio pressure

after epinephrine aha] 1 enge as compared with ccmtrols J however, this inorease

wu not statisticalq' significant (Tables 2a, b).
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Net increase in diastolic pressure produced by epinephrine, in ATP pretreated
animals, was virtuall,y identical to that observed in saline pretreated
controls (Tables 2a, b).

If the increase :in diastolic pressure in ATP

pretreated an1mal.s is expressed as a percentage increase the rise following
epinephrine in both systolic and diastolic pressures exceeds the values for
thyrox:ine, which is reported to accentuate the medial damage produced b,y
epinephrine (Michulloich and Oester, . 1951). Although the above data raise
questions regarding the sole importance of systolic and diastolic blood
pressure changes following infusion of epinephrine as etiological factors in
medial arteriopatby it should be kept in mind that these results were obtained
in acute experiments.

It is entirel\Y posaible that subacute administration

ot these various drugs could coneeivabl\Y alter interpretation of the
etiological role ot pressor effects •
.Ana:qsis of heDlOdynamie data bued on the pre-infusion systolic
and diastolic pressure suggests scme correlation ma;r axist between the
ability ot a given dNg to increase or decrease sY'ltol1c and diastolic
pressures and the ability of a drug to intensi.t'y or prevent medial arteriopa'tbJ'.

Thus AfP and phentoludne, reported to be of value in preventing

epinephrine arteriopathy, (Davis et al., 19$$, O'SUllivan, 1962) decreased
systolic and diastolic pressures to a greater extent than the other drugs
studied (Tables la, 2a).

Conversel\Y, th3'rox1ne which according to Michulicich

and Oester (19$1) augments epinephrine arteriopathy was most potent in
increasing systolic and diastolic pressure prior to epinephrine infusion.
However, iproniazid at a dose reported by O'Sullivan (l962) to augment
epinephrine arteriopathy, decreased pre-infusion systoliC and diastolic
pressurefJ (Tables la, 2a).
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'fbWl, mod1f1cat1on

or the epinepr..ri...'1e pressor respc:nse toll..ow1ng va:rious

drugtJ does not appear to be who1J;y consistent with a hemodynamic etiology ot

epinephrine arteriopat.J:v; yet, the possibility cannot be excluded that other
tacets or extensions of cardiovascular studies could show positive

correlati0ll8.

-

Recent studies tram another laboratory question the sole importance
of' vasopressor effects in producing arterial lesions.

Gu'tstein and Cooper

or Vasopressin either
wael:ly rar a period ot 6 to

(1964) have reported. that intravenous adDdnistratim

1ntravenousl¥ or intraper1taneally thrae times
11 weeks did not produce

any'

observable :u-terial lesions. When, however ..

this regi.'I1el1 was supplemented by ooncmtant oholesterol feeding, medial and
intimal caloif:tcation was observed in abont )OjC of the animallh

Outatein

(personal camn.lltlicatiCll) has indicated "We are in cOl1p1ete agree.1tl.ent with
your statement that, factors other than vasop't"88sor etfects alone !Il8T plq

an iq>ortant role in the development o! this type ot pathology."
A similar position in regard to medial sclerosis has been taken
by Milch and loxtennan (1964) who have taken issue wittl Lorenzen t 8 (19S9 ..

]96la, b) suggestion that medial sclerosis following epmepbr1ne is
cCIlsequenee of the vasopressor etfects of this drug.

(l964) bave recent17 stated that in their

II

Milch and Loxte:rman.

op1niClll "Lorenzen t s data are

subject to add1.tional 1nt,erpretation :in that his results also support the
Jv'pothesis tba.t epinephrine initiates and B.ggntVates a detect in the
"biochEmical architecture" of aortal wall whioh rende" it susceptible to
degenerative cbange, and that the defect 1s manifested bT an alteration in

aortal IlUcopol¥saccharide metabolism".

In the analTa1a ot their studies CIl

lIUCopolpaechar1de metabolial of' the rabb1t aorta JW.ch and Loxteraan (1964)

oCllolude, "the data support. the hypothea1s that epmephrine induces a detect
111 the

b1och~ cal

arcb!t.ecture of the arterial wall 'llh1ch rendere 1t

auaceptible t.o degeneratbe change".

Further analysis of significance of presser effects suggests that
11' arterial damage is a sole or primary emseqnenee of vasopressor ettecte
a

co~e1atian

should exist bet17eel'1 arena ot me.."tfmal. pressure and loca1:!.£a-

tim of lesions.

'the presl.':tt'!"e pu1so JnOVinC toward the periphery at a

velocity considembly 1.n excess or the

vl?loe~.ty

or

eorpuseu:t.ar elements ot

t.he blood causes a. rebound of blood from rec'_Of!s of sharpJ;r inoreas:J.ng

:resistance, thus giving rise to a decrementing d:tphaeic eentripete.lwav8,
(wiggers J

19S'-'. Smce this centripetal wave and the preefml"e pulse are

both present in the same system of "1a1bea'l J they &!nlJ'lm&te effecting a major
alteration in contour of the pressure pulse. !he propagat1cn of th1a
refleoted pu.lse 113 deeremen.tal.

'!herefore I a greater 8Dq)litude 18 aTailable

at the more distal portions of the arterl.al tree givtng rise to a greater
net \lave

~11tude.

At points

lUOl!*e

prad.mal to the 't'entr:1cle the attenuatecl

reflected wave caulln less ot a mod:1tlcatlon of the 't'entrtcular pulse and
'the rosultant arterial pulse 18 louer in magnitude.

'!'hus cctrV7 to a:pectat.1ona the aapl1tud.e ot the prunre
pulae recorded at points

JIlOJ!"8

distal. to the heart 18 increased in

ampl1t11de and therefore the prean.re recorded at .... d1atal pointe 18
greater :in magn.1t.ude than at points more prox1mal to the heart.
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Thus if the mechanical effects of the pulse wave were the sole factors
operant in medial damage it would be expected that the lesions would occur
at maxima of the reflected ventricular waves.
lesions in the more peripheral arteries.

Such maxima would place medial

Roszkowski (1956) in discussing

localization of epinephrine induced lesions stated "In general .. only the
thoraciC aorta was involved." Ie further states "Apparently' large trunks
are the vessels primarily' affected.. small arteries and arterioles did not
appear to be altered." This apparent lack of correlation between pulse
wave maxima and localization of arterial lesions does not however campletely' rule out the importance of hemodynamic factors.

It is entirely

possible that mechanical effects of the arterial pulse wave might exert
their damaging effects not at their maxima, but rather at sites in the
arterial wall which by their structural or biochem1ca.l characteristics are
particularly' susceptible to mechanical damage.

Such an interpretation is

consistent with Blumenthal'. (1959),hypothesis.
A recent study by Wolinsky and Glagov (1964) examined the effects
of intramural tension on the static mechanical properties of the rabbit

aorta.

In their experiments the rabbit aorta was removed under anesthesia

and all branches tied.

The aorta was washed in saline and attached to a

cannula at the proximal end .. while the distal end was closed by a pinch
clamp.

After placing the preparation into a small airtight chamber ..

various hydrostatic pressures were applied to the isolated arterial segment.

Then.. the saline was flushed out by a fixative solu·tion and after

a sui table period (usually 2 hours).. the segment was removed and. IrJtudied
by both conventional histological techniques as well as via electron microscopy.

Several observations pertinent to the present discussion were made.

Wolinsq and GlagOV' (1964) found that at ph3"Siological pressures the aortic
media tunot.ions aa a two phase system in which the ·c1roumferentie.ll\r aligned

collagen fibers bear the tangential etressmg foroea while the elestin net
distributee the stressing forces uni£onUv throughout the wall"'.

The intra....

lwdnal pres.urea employed 1n their stu.dies varied between; and 200 lIIIIHg.

S1milarq Roach and Burtcn (1957) MacDcnald (1960) and Bergel (1961)
have

s~asted

on the basis of their studies that the

o~erent~

arranged m.edial collagen is the effective struct.ural compment of the aorta a

and above physiological presnr8s.

O'SUllivan's (l962) description of rupt

of longituditla.l elastic fibers the t1r&t

WV' after adm1n1stration of epin....

phrine 18 d1t:f'lcu1t to reconcUe with theae reports.

Wollnsq and Glagov

(l964) state that because of the two phase structural system present :In the

rabbit aorta the ao:t'e extensible elast:in compane.nt distributes the stress.
un1tormJ,. and that stresses around flaW8 are transferred to other parts of

the arterial wall. Also mentiCl1ed is the observation that ..the aorta rarelT
breaks despite nwaerous irregularities and f'law. of ccmpoe1tim and archi-

tecture wb1ch 1ncreue with age. 1t In their ccncluding remarks Wollnaky and
Olagov (l964) state tttocalaed1al detects and med.1al pressure and tena1cn

gradicts IIUV' be

relatlve~

insignificant factors in the development of' aorti

diseas.·. Untortunat.eq theae studies were performed using stat:l.c rather

pulsating pressures and therefO1"e do not c01"l"elate as cloaeq with in-vitro
cmdltic:ruJ as might be de.ired.

It should alao be emphasozecl that the studi

ot Wolinsq and Glagov do not prectiLnde the occurrence of focal med1al

l.eaiCl18

in the .ona.

Although the preceding discuu1cm raises a number of' questions
ccncerning the s1gn1f1cance

or

pressor etrects. it does not obviate the

participation of all cal'diovascular phenomena in the genesis of EPinephrine
induced arteriopathJ.
signi.fieance.

en. 'such

aspect., tqdr08tatic tension, maY' be of

Tension in a. given Tessel is

811

expression of the stretching

force exerted by the hydrostatic pressure m the vessel wa1.1, which in turn is
opposed by the tensicn developed 1.."1 the wall of the vessel bT its smooth

Illusele and elastic components. Hydr08tatic tension in a vessel III81' be calculated by applying the law of Laplace, represented by the
~ll

~ation

r- P x R;

Which P is the excess ot the hydrostatic pressure maida the vessel over

the local surrounding tiBsue pressure in dynes/em. 2 J TJ the tension developed
in the wall in dynes per square centimeterJ and R, the radius of the cylinder
in centimeters (MacDmal<i, ).960).

Using literature data Blumenthal (19,6) has

calculated levels of hydrostat1e tension in various arteries.

Thus, in an

a.orta with a radius of 1.3 em. and a mean pressure of 100 mm..Hg., the tensim
on the wall was oalculated to be 170,000 d:¥n••/cm. 2 • In arteries such
hepatic or splenic having a smaJJer radius, eg.
calculated to be 20,000 dynes/em. 2 •

0.15

8.$

the

ems., the tensiCll was

In the rabbit aorta the bTdrostatic

tension acting on the veasel wall should therefore be ccnsiderabll' higher than

that £ound 1n vessels of smaller radius as the feaoral artery.
gradient would. parallel the localliation

reported by Roazkowsld. (19S6).

or

Such a tansioa.

epinephrine induced lesions

This Una of reascning suggests that protec-

tion against possible mec.hs.Idcal aspects of epinephrine induced arler:Lal

damaae could

be produced by reduction of arterial presffa:re changes via

decrease in per1,pheral resietance, accompanied
aortic radius.

by no change or a decrease ill

RegretablT such qualitative data

CI'l

these parameters was not

obtained in the present study, due to t.be difficulties attendant in their

deter'lldnatim.
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Biochemical A!)?!Cts
from the very outset of this examination of epinephrine induced
medial aelerosis the uniqueness of the lletaboliSlll ot &rter1a1 tissue bee. .

evident.

cae of the strildng points noted was that aortic tiHl1e exhibits a

rather low respiratol7' rate.

Kirk et ale (19,3, 19,4) have reported that the

respiratory rate of human aortic tissue is onJ¥ about

Brills et al.

(19~)

~

that of liver tissue

have reported that in the rat aortic respiration proceeda1

in Titro at a rate abou,t one-ta1th that of liver slices from the same animal.

RegrettabJ, these two studies did not otter compari.sons of aortic tisll\1e with
intest1nal SIIlOOth muscle or skeletal muscle.

'ontaine et al. (l96O) have

reported that in the ax: aorta sixty to n1nav percent of glucose is metabol1aed T1a gl\rColy'sia. while most of the remainder varying tr_ 10 to
metabol.1sed via the Ireba cycle.

3~

is

To the cmtrary, the liver exhibits an

aerobic clrcolTlis ot about 30 to 4O,C and oxidative metabol18m of about 60 to
70%.

'fuus the etticiency of carbob1'drate m.etabo1ia1l11n aortic tissue is mq

abo\tt 4~ of that observed in liver (Fmtaine_et

al.,

196O). 1irk (1963)

has calculated d1ffusim eoefficiEllts for OJCRen in human aortic tia8\le and

ltates "These enimated depths to wbleb OXTien can penetrate through d1ff'uaicm
indicate a low margin of rese",e for the ax;rgen auppq of the normal aort1o

wall." Lehn1nger (19,ge) has also indicated that "If the diffusion of oqgc
to the cella in the media is at all limited, then it can reasonabJ, 'be

apected that the d1ftu1on ot glueOH, the aubstrate for alveoll'si. must alao
be liIlited, &ince both are 'brought into the cella by ph;vsical d1ffu81m, so

tar as is

mO.h lt

fontaine et al. (1960) has indicated that distances between

adjacent capillaries "in parenchylllatous organs averages frcm ten to thirty'
microrul, but it increase. to five hundred microns tor ar\erial walls, thus

11

illustrating the poor vascularization coming from the vasa vasorwn."

This

compares with mean capillary distances of 17 to 83 microns in skeletal
muscle (Pearson 1962).

A similar position is held by Kirk et a1. (1955)

who state that the arterial wall fed either by diffus10n fram the lumen
or by the vasa vasorum in the advent1 tia and media presents extended
diffusion distances for the inward passage of substrate and oxygen and
outward diffus10n of metabolites.

Another peculiarity of arterial tissue

is its low concentration of ATP which in the ox aorta 1s approximately
1. 34 lM/IOO gma. (Kempf et ale 19(1).

Th1s level is only about two to

four percent of that reported in skeletal. muscle by Bendall and Davey (1957~.

The rather low metabolic efflciency and extended dlffusion paths
for metabolic substrates in the aorta suggested that this tlssue might be
susceptible to blochemical defects.

Therefore, several. exploratory studies

were undertaken in an effort to survey blochemical aspects of arterial
metabolism which might be profitably explored to gain insight into possible
biochemical aspects of epinephrine artenopathy.

In the course of such

pl10t experiments it was found that lncreases in blood glucose and lactic
acid following epinephrine levelled off approximately two to three hours
atter administration of this drug.

Subsequently tissue experiments were

conducted ln which aortic levels of glycogen, phosphate, and lactic acid
were determined at two, four and eight hours atter epinephrine administration in fasted rabbits.

A significant deplet10n in aortlc glycogen vas

observed four hours after eplnephrine administration.

This decrease in

glycogen of approximately 40;' was paralleled by a decrease of approximate~
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6f:II, in skeletal

DlUSCle.

and skeletal muscle

41

40

At the peak depletion time aorta contained
mgs.~

gll'cogen (Table

4)..

mgs.~

The _ller percentage

decrease in aortic glycogen is intel1:)Med u being in part a consequence of a
lower level of epinephrine controlled glycol;rtic activit)" in tb18 tisaue.
Such an interpretation 18 consistent with the report by ltla1ner et ale (1962)
who reported a ve1'7 low level of cyclase in dog aorta as compared with dog
skel.etal !IWIcle.

Since Fouta (l962) hu reported oumulative ettects on drug

JI8't,ab-

011_ tollowing repeated epinephrine administration, 8Ubacute exper1Mnts were
conducted in which epinephrine, th7rox1ne, and epinephrine plus thJrox1ne were
adm:1nistered daily for a period of two weeks, in accordance with the procedures used by Gester et ale (19S4, 19$9). Drug adm1nistratim was tel"ldnated
twenty-four hours prerl.oua to autopsy with the expectation that

arrr

altera-

tion. in levels of tissue constituents would be of a sub-acute rather than
acute nature.

Aortic glycogen levels which on an acute basis were decreased

b)" epinephrine, were not sign1.ticantly changed b)" subacute epinephrine

adm1nistraticm.

'!bTrox1ne adm1n1stration for a two week period did :esult in

a slight decrease in aortic cll'oogen, an effect which appeared to be
potentiated by cCllcomitant administration of epinephrine (Fig. lO, Table $).
COIIIParative detel'llinationl on skeletal mu8cle indicated no stat1atically
s1gnitioant changes of cqcogen level in any of the groups.

Aortic glucose

l ...e18 were 81gn1.t1cantly elevated in an:!.mala treated with epinephrine or
epinephrine plus thJrox1ne
a1gnif'icantly emated

(rig. n,

Table 6).

Skeletal l'IlWJC18 glucose was

cnq in an:i:llall recei'rlng epinephrine alene. Subacute

epinephrine alone or in cexnb1nation with tb1radne did not produce an)"
significant changes in lactic dehydrogenase or lactic acid levels in the

19
aorla (Tables

1, 8).

Tbe lower levela of aortic phosphate (Table 9) observed in both
thyroxine treated groups are difficult to reconcile w1th Hooh' s (l962)
statement that tissue levels of inorganic phosphate

usu.al.l1' rise

treated with th1'rox1ne and are contrary to our expectations.

in animala

Thus in the

biochemical studies a few changes occurred which appear to be related to
effects of epinephrine on oarbolV'drate metabo1:1.sm.

'lbe acute depletiCll of

aortic gqcogen following epinephrine appears to be a consequence of stimulaticm of glTcoqs1s.

The subacute increase in aortic glucose could. be

interpreted as a decrease in ut1l1zaticn or a consequence of increased uptake
f'rora the blood.

Metabolic Studies U.illl RadioisotopicaJJ, Labelled Subetrates
The•• studi.s disclosed several points which ma.Y be important
(Fig.

l6-2S,

Tabl••

10-14).

Th. first of these, st1m.ul.atim of

c14o.z

produc-

tion by epinephrine, was a rather consistent fincHn'b when aortic tissue was
1ncubated in a medium cmta1n1ng glucose-6-C14 (Fig. 16-19, Tables 10, ll, 13)
Pretreatment of animals for two weeks with thyroxine prior to aperiments more
than doubled

c14~ production f'rcm glucose-6-C14 (Figs. 16, 11). \l;llen aortic

tissue was :incubated in a mediUDl cCIIUJist1ng of Krebs-Ringer bicarbCllate
+

o. ~ml.

of non labelled glucose and glUC08e-6-C14 as a labelled IUbstrate

an accentuatim of the effects of epinephrine were noted.

Under the.e cClldi-

tions epinephrine addition increased the fonaation of labelled carbon dioxide
nearll' tonrfold, (rigs. 19, 22, Table 11) while norepinephrine appeared
impotent (Table 13).

m,

phctolam1ne and phenQ1q'bensam1ne appeared to

1nh1bit this st1Dmlating effect of ep1nephr1ne (Table U).

Phctolam1ne,

80

which according to O'Sullivan (1962) is

mO.r8

effective in preventing

epinephrine artenapathy' than phsOJq'benzandne was the more effective of the
two drugs in this regard, even lowering

ol402

production to aub-control levels

(see Fig. 19). A'tP which according to Davia at al. (1955) is also an
excellent propb;ylactic agent against epinephrine art.eriopatbT did not inhibit

c~ productim to as great an extent

&8

either phenOJq'benzamine or phentol~

audne suggesting that its role as a preventive agent may be unrelated to its

ettects on carbohydrate metabolism.
Under similar ccnditions aortic tis8Uef'rom animals pretreated with
thyroxine for two weeks exhibited a rate of

c1402 production trice that

obsel"'V8d in centrol tissues f'rcm normal animals (Figs. 20, 23, Table 12).

However, the rate of formation of' labelled carbal dioxide b.r normal aortic
tissue under the inf'luence of epinephrine was nearq double that found in the
case of the thyroid controls.

Aortic tissue from thyroxine pretreated animals

vas also susceptible to the metabolic stimulating effect of epinephrine in
that addition ot epinephrine nearl¥ doubled

tig•• 20, 23, Table 12).

c1402 production

in these tisn..

Aa in the case of' aortic tissue from normal animals

both phentolaine and phenox;rbensamine 1nh1b1ted the epinephrine st1mulating

effect, the latter drug being less effective in this regard.

A'tP did not

appear to affect the epinephrine induced stimlllatim of metabolism in tissue
from thyroxine pretreated animals.

From the above cl1acusaion it is apparent that there JI87 be a
correlation betweSl atim"] ..tim or 1nh1bitim of OJd.dation via the Krebs c,ycle
and production

tR

prevention of epinephrine arteriopatby.

Thus, epinephrine

which when adminiatered alme to rabbits on a subacute basis produced medial
arterial sclerosis (OesteI' 1959) also causes a substantial rise 1n rate of'

8

axidation via the Krebs cycle.
Thy'rt'Xldne administered alone on a subacute basis does not produce
medial sclerosis, but when administered concurrently with epinephrine appears
to greatq potentiate the sclerogenic effect of' the latter drug (Michulicich
and Oester 19,1). In the studies where unlabelled glucose was present in the
medium the rate of oxidation of labelled glucose although higber in thyroxine
pretreated animals did not reach the levels produced in nonal animals by
epinephrine (Figs. 20" 2), Tables 11. 12).

There alao appears to be a

consistmt relationship between the potency of the two adrenergic blocldng

agents in inhibiting oxidation by arterial tissue under the influence of
epinephrine and the ability to protect aga1nst epinephrine sclerosis in the

intact animal.

PhCltoludne which is the more potent of the two drugs in

inhibiting epinephrine sclerosis (O'SulliVWt 1962) i8 also more potent in
1nh1biting oxidation by aortic tissue treated with epinephrine.

It mq be

recalled that phentolamine and phenoxybenzudne showed 8:5 mi lar potency- in

inhibiting the pressor effect of epinephrine in the intact animal.

Thus in

this case there appears to be a better correlatim between metabolic 1nhibi-

tion and ability to protect aga1nat epinephrine sclerosi8 than is the case in

regard to inhibition of pressor efrects.
Hexose Monq>hosphate Shunt
In aortic tissue from normal animals the Tield of clla.02 obtained
from. glucose labelled in the number one position was near:t,' twice that obt

from glucotSe labelled :in the nUllber six poe!t10n (Figa. 19, 20, 22, 2).
Similar observation. have been made b7 W'inegrad et al. (l9S8) and

(l96O) in adipose tissue.

J¥nn et al.

Sbarra et &1. (1960) have reported that production

of labelled carbon dioxide by guinea pig aorta is poeater when the glucose

substrate is labelled :in the number me positim than when the label is :In the

number six position, paralleling our results.

'!'he yield of c14~ !'rom. glucos.

6-014 is believed to reflect oxidation via the Krebs cy'o18, while the increase
in yield. of labelled CO2 from glucose-l-C14 i8 belitNed t.o be a cQlsequance of
the participation of the hexose monophoBphate shunt (ph08pbogluconate

ox1dative patbwq).
It the huoae monopboaphate shunt is not preBalt or operant in a

partioular tissue the yield of radioactive carbm dioxide ill the same regardlesa whether the label is :In the one ar six position.

'i'be dUferential

observed in our experiments thus, suggests that, since the Tield ot radioactive carbUldioxide is greater when glucose-l-C14 i8 used as a substrate as
compared with glucose l.a\>ttUed in the six position the hexose monophosphate
shunt is operant in rabbit aorta.
In aortic tiuue from normal aniuls the ratio

ot

c1402 formed

fr_

gluco.e-l-C14 as ccmpared with that tormed frOll glucose-6-C14 vas about two
(Fig. 19, Table

14). This same ratio

in aortic tissue from animals pretreated

far two weeks with thyroxine vas approx1mateljr six, thus indicating a rather
significant st1mulatiCll of the hexose llOllophosphate shunt by tlly'roxine in this
tillsue (r1g. 2), Table

14).

When epinephrine was added to aortic tusue from nOl'Jlal an1.mals

(Fig. 19), yield of labelled. carbcn dioxide trOll glucosa-6-C14 vas increased
almost tour fold.

en the other hmd,

c14 vaa used as a substrate the
by

:In similar exper.lm.ants where glucose-l...

yield ot labelled carbal dioxide was increued

(I'lli' a factor ot less than fift,. percent. The added increment ill inter-

preted as stimulation ot oxidative phosphorylation in the Krebs cycle with no

8
Sl':Psrent stimulation ot the hexose nom.ophosphate shunt, but rather in inhibi...
tim of catabolism via tM.s route.
Aortic samplee from. tIvroxine nretreated. anir.Lals challenged with
epinephrine exhibited a. level of' c~ from glucose-l..c 14 whioh was not
significantly d:if:t'arent fran that observed in controls (Figs. 20, 23, Table
This observation indicates that an inhibition of the hexose monophosphate

sm.mt occurred in thyroxine pretreated animals.
It is felt that the data obtained on the participation of the hexose
manophoapbate shunt in nomal and thyrox:1ne pretreated aorta may

as~ist

in the

resolution of certain inconsistencies in interpretation of the pharmacological
role of thyroxine in experimental arteriosclerosis. It 1. a wen know faci;
that conec:xn1tant adm:1n1stratim of th;vTax1ne to aninlals on a high cholest,erol
diet provides protectian againut atheroma formation (Constant1!lides 1960).
C(xl'\"erse~

rabbits treated with epinephrine and tl'1¥roJdne appear to be more

prone to dev9lopment of arterial lesions when cholesterol is administered
intravenousl;r !>ester et &1. (195SD or when ted in the diet (Constantinides

at al.. (l96O~.
Koritz and Peren (1957) have reported that TPHH and hexose monopho.phate shunt enzymes are required for steroid biosynthesis in oell tree systems.
Thus" i t is possible that the 'lftH generated in the hexose monophosphate shunt
is utilized in the "detoxit1catim" of' chole.terol making it more vater
soluble and thus inoreasing its potential for removal. and excretion via the

kidney.

This supposition is further strengthened

and WiU:Sa.u-Ashman

b.T the report

(19,8) that estradiol appears to :f.'unctiQ.Yl as an. essential

co-factor :in a DPB-'fPNB Unked transhydrogenation reaction.
incidence

or

by' 'l'alalq

CO!'Cll&ry'

Also, the lower

arteriosclerosis in premenopausal females haa been

ascribed to andogonOU::i estrof;en.

Thus, if cholest.erol atherosclerosis 18

looked upcn as a. ctXls€lquence of irJ.su!ticient he:;s;ose monophosphate shunt
act.ivity, drugs which sti.1lUlate shunt activity should proYide protection
U6ainst athez·oscleroais.

Our findings which show a rather striking stinrJ.l.a-

tion of the hexose rtlOnophosphata shunt activity by thyrcotil'lO lI'lltiiost that this
~

be the cue.

The potentiation of cholesterol athercxna formation by

epinephrine-tl:lyrOJdne regimen may be a consequence ot the :inhibition of this
shunt by epinephrine.

OUr studies indicate that suoh

'::<-1

inhibition does

OCCU1'\

Prom. our discuasiorL of the stimtllatmg effect of epinephr'lne on

c14~

productic:n trom glucose-6-C14 by

a~erial t1s~

this increase in metabolism 1& Primaril3' if' no1i

Krebs cycle.

8ols~

it is apparent that

due to effeeta en the

Since it is generall¥ believed that the mitochcmdria are the

site of oxidative phoepho1"1'latiOD via the Krebs cycle we feel that it might be
rea.a<nable to postulate a hlPot.hetical site of aetim for epinephrine on the
mitoobcndrion in arterial tissue.

If the increase in oxidative phoaphorylaticn is due to a 8welllng
of arterial mitochondria _ m1.gbt expect some parall.eliam between Haulta
which we have obtained and data reported on the swell1ng of Ddtochondr1a by'

Lehninger (19$9a. c) and others.

Chappel (19S8) haa reported. that the

swelling of hepatic mitochondria ill pot.entiated by addition of substrate and

does not occur in the presence ot metabolic inhibitors or ab.coe of amostr. .
It we

CCIIIIJ)U'e the

results obtained in aortic

.~lea

incubated in a medium

free of non-labelled glucose with studies in which O.5JWml.. of non-labelled
glucose was added (Figs. 1.8, 19) we will note that in the latter case (0£
added substrate) the effect of epinephrine 18 vaatq enhanced.

Results

observed with ImP alene were s:l.milar to those which D.B alone was used a. a
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aed1um.

Thus, i t epinephrine acted in a unner similar to that of

t~e

we would expect that the extent of swelling and subsequent increase in metab011_ would be greater in a medium containing glucose than in its absence.

Such an etfect was noted in the mB and DB + nCll-labelled glucose experiments
(Figs. 18, 19, Tables 10, 11, 13).

Lehninger (19,9b) has reported that

thyrClDdne induced swelling ot mitochondria can be prevented or reversed by
addition of A'fP.

Inhibition of epinephrine induced increase in oxidaticm by

i l l could pos.lbll" be uplai."led by aasUDdng that

&8

in the case of thyroxine,

A'l'P :1nh1bits the mitochondrial swel.l1ng produced by epinephrine and tbus

inhibits the increase in oxidative phosphor.rlation.
udne and phenox;ybenumine are less clear.

The effects of phentol...

It might be proposed that these

drugs act by' interfering with the postulated ...ellin, effect ot epinephrine of

arterial mitochOl'ldria or that the,y :IIlV cause a cmtractiOll of IlitochClldria
.ither directq ,. ind1rectlsY.

In any event .... do teel that our tindings

suggest that nudies of pouible eftects of epinephrine on arterial Dd.\ochon-

dria might be protitab:q a:plored.
According to Zamecn.1k (19S4) addition of ATP to t18sue slices
inereaaes the incorpOl"at1cm ot 1Botopicall3 labelled amino ac1ds into protein.

Converaeq Boob (1962) indicated that thyroxine in h1gb doses is bel1wed to
inhibit protein synthesis.
'!hus, 1t ...as telt that investigaticm of the ettects ot epinephrin.,

thyroxin. and UP on the incorporatim ot 014 un1f~ labelled 37sme into

aortic protein

Blight prari.de

SCIIIe

suggestim u to a possible mechanism by

which epinephrine causes medial arteriopathT.
The nudie. which were performed indicated that epinephrine signiti-

cantll' decreased the incorporatiCll ot unit~ labelled 37sine 0.lJ.a. into
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arterial protein (Figs_ 24, 2S, fable 1$). Incorporation of labelled qSine
into protein we alao 81@Pir1oantl;r inhibited in aortic tissue obtained trCilll

.Smale pretreated for two weeks with

t~oxine.

Noteworthy was the observa-

tim that protein synthesis s1gnificantl¥ depressed by t.by-rax1ne pretreatmEnt
of animals vu 1'urther depressed by addlt1Cl1 of epinephrine to the ineubatiCll
f'lulal (Fig. 2$, Table 1$).

Neither phentolamine or phEmO'll'benzam1ne appeared

to s1gnit1cantl¥ 1nh:1l>1t the depressim of protein synthesis caused by' epin....

phrine, which was nullified by ATP.
Data &CC\1ll1Ulated on both protein synthesiS and carboh7drate

metabolism suggest that drugs involved in :lnductiCll, potctiation or prevention of epinephrine induced medial arteriopathy exert an effect an the meta.boool.iam of arterial tissue which 1n general is consistent with their role in

art.eriopatby.

Epinephrine, sine qua non, appears to affect not onlT oxidative

phosphorylatim but also appears to exert an inhibitol'7 effect on protein
synthesis,

'!he 1nh:1l>itioo

ot protein synthesis observed ma;r

of the effect of epinephrine on A.!P availability.

be a cCIlsequenoe

Since At}' has been found. to

be essmtial for amino acid activation, reduction in tiasue A'1'P should result

in reduced protein ayntheaie •
.An

mer....

in oxidative phoaphor,ylation follow1ng addition of

epintphr1ne to arterial tissue should reeult in a higher tiasue ATP level, but
~

i f the rate of destructim of AT' ..ere unaltered.

auggest that this 1Iq not be the ca...

Two :recent reporla

Stamm. and Honig (1962) have reported

that epinephrine interferes with the inhibition of cardiac aden081nephoapha-

tue activiV by' the so called relaxing substance (BS).

Acoording to Parker

and Gergel3 (1960) RS 1s an important pbTeio1og1cal modifier of 1I\fotibrillar

ATP-ase activity' and is thought to terainate oantraction in heart muscle by

8

inhibiting ATP hydrolysis.

In Stamm and Honig'. (1962) experiments RS obtaiDad

from cardiac muac1e inhibited cardiac AfP-ase by approximately t0X't7 percent.
Epinephrine addition to the incubation nd.xture containing both ATP-ase and IS
decreased this inhibition bT appraximately 16%.

This ef1"ect a.ppeared to be

doe. dependent since lower cQlcentrations of epinephrine caused less inhibition of the IS activity.

If'nn et 1.1. (1960) have indicated that in adipose

tissue "epinephrine and AC'1'H promote the synthesis 01" ADP from ATPU.

'ftle,r

also 81J.ggest that the stimulation 01" resplratiCll b,y epinephrine 1n adipose
tissue may be mediated via this effect, since it is generally accepted that

tis8Ue ADP level is one o! the fa,otors cClltrollL"lg l'flte 01" carhobJdrate
metaboJJ.am.

InUl1lUCh as epinephrine has been reported to have an -uncouplingetfeet on ;lTP it is entirel¥ possible that such an effect Obtalx18 in arterial
tissue.

If epinephrine increased the level 01" avaUable ATP we m1ght e:xpect

that protein .,-nthesis wwld be stimulated when epinephrine was added to
arterial tissue.

Such an effect was not ob.erved.

If the tissue ATP leTel

was a l1m1t1ng factor in depres.ion ot protein eynthes1s
would expect A'tP to reverse this inhibition.

by epinephrine we

'ftd8 effect was observed.

Addition of A'tP to arterial tissue where protein eyntbesis i8 depressed by
ep:1nephr1ne resulted in a l'flte ot protem synthesis simUar to that :in
controls.

Thus, there 18 reason to believe that inhibition of protein

synthesis by ep:1nephrine ..,. be 1.1nked to UP availabU1ty.

A possible axplanatial of protective action provided by phentolamine lUI' lie 1n substrate ccn8ervatim.
produced deplet10n 01" aortic gl1'cogen.

As 1nd1cated previouaq ep1nephr1ne
This effect appeared to be accentuated

by concomitant administration of epinephrine and tbyrox1De.

Breit.tar (19$6)

has reported that adrenergic bloc1d.na agent. can prevent the thy'roxine induced

inorease 1n raeta'bo1.ism.

The r.ulta obtained in the present 1nvest1gat1cm are

cons1atent with hi. f1ndings since additioll

or

phetltoludne to arterial tiawe

frOia tiW-l'OlUn8 and epinephrine pretreated an:iJlal8 rfisl.\l.ted in

c14~

productic

which vu 01' the .sue urder of mat;nltude ae that observed in aorUc sample.

i'rom

1'1armal

ard.mala not pretreated with tb,yrox1ne and epinephrine.

'lb.G leu

potent aot,iv11iy of phflll0X7ber:lzaino in pnrnIlt,lng epmephr1ne acle:roau
p.araUels It.s lager potency 1n regard to 1nh1b1\1ng ad.d&t1ve pboaph..,-latiCil
by

.ortio tuaue.
Failure

or

norepinephrine to c1gnit1cant.l;v increase Kreba cycle

a.d.daUOIlb,r aortic tiafte b consistent with ita l.oIHr potency in 1nduc1nl
medial arteriopatb7 aa conpared "ith epinepbrit1e reported

(l9S'., b).

Both druca produce effects

Alt.bcach the abon 41acuee1ol1
e.x1.atance

or

it should. be

aystol1c pruaure which are

has PNMnt.«i ft1denoe suggesting the

a aetabol1o oOllPClDent 1n the IGA1.al. of epinephrine arteriopa\llT
~b.t

that Sl1 rive da'- doe. not neouaar1J, Nflect

obaDgea wh10h T.ake place in the
t1asUfI

Ql

tv Fl"ledman et 81.

au.ttera fn:a •

.t~onrsal1n\Kt

an1mal. In viVo :\.n4,uba'ttion. of

n\ll'Ilber of ahortcom:J.op ;in that unavo1dabl.e

t:t'1lUM

WNall;y OCCUft in prepantlon of the u.ue IUlPle, \he 1neubatiGn ...lUll on

pee8ll'
to

0CCt.ll'

approx1mata that present nomal.ll' and iD .... CU. . I'f*)t:tan.. found

in isolated t11.8 proceed Gftly to a lJ.m:1ted ext.alt in tbttl intaot

animal. Dwp!.te th..., di8liift:ltq.. in vitro incubat.lon hal 1n a
lnstance. f.efIl'l uaef.ul in
oouplclot

.,-at_.

~din.S limpls

!lUl\\ber

of

aodela useful in the fJtuf!y of 'DOre

Ocnclusi0l8
In general, a poor- correlation was obsM'Ted between the abilitT of

drugs studied to modit)'.. on an acute basis .. the pressor response t.o epine-

phrine, and their rela:t.lve effectiveness in preventing Or augmeuting
epinephrine

arteriopa~

a.e reported by other inveetigatorlh

For

exa.~le

thyrcDdne which signifieantlQ augments epinephr:ina arteriopatlv (Michulle1ch
end Oeater, 1951) did not potentiate the net rise in STl1.\)l1c and diastolic

bl..ood pressure fol.lurlrli; epinephrine.

The net pressor rise foll.aw1ng

norep:tnephrlne dld not signifieantl,- differ with that obserYed toll..ow:lni
epinephrine, however norepin.ephrine administered on a subacute oo.sis ill
reported to cause a lower incidence snd severity of medial !esiells than
epinephrine

triedlun et

al.

39"a,

'b).

Uthough phentolamine and phenOXT-

benzam1ne were found to be similar 1n their ability to reduce the pressor
respcmse following epinephrine, phel'l:tola.n:dne is reported to be more active as

a prCPhTlaet1c agent

m

V$

epinephrine artariq>athy" (OtSulliT8Jl, 1962).

which 18 reported to be one

or the II!.08t pot8'lt prophylactic

a,gents w ep1nephl'1ne arter:Lopathy, wa. less etteetive in 1nhlb'.ting the net
epmephrine pressor effect than phEl'lOll;1ben.ltmine whiclJ. is re1at1velT 1mpotct

in this regard•
.CD. the other hand t.he deereases in pre-infusion s.ratol1c and

diastolic pressures prmuced by' ATP and phentolurlne appu:r to pa.rallel their

prophylactic value in ep1."lepbrine arter1opat.bT as reported b7 Davis at 81.
(19S5) and O'SU.ll1van (1962).

The possibility that protec~ion against

mechanical aspects of epinephrme induced arterial dmu.ge could be a. em....
Clllence of reduct1m of intravascular wall temd.CI:! 111 raised.

A.lthouch the

present report, questt.ona the importance of increuea in .78tolic and
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diastolic preuure8 in the genesis of epinephrine arteriopathy, it 18 entirelT
possible that acute oardiovascular relationships noted in the present study
'IIa7 not retlect subacute cardicmulc'Ular .ffects.

Data in th1a report suggest that study
metabolic eftects of epmepbr1ne

<Xl

or

the relatlvel;y unexplored

arterial tune ..., asa1at in the ident1-

tioaU_ of a specific leal. or lesions which precipitate medial arterlopatl'r.
Tbe rather significant effects of ep1nephrine 111 potentiating Krebs cycle
oxidatiGD, 1nb1b1t.1an ot protein synt.beata and 1nh1blt1on o.t ox1dat.1. via the
huon JD"lophospbate shunt auggut f'urther areas tor profitable 'lnveat1gation.

It 111 the op1niGll of the author that one or more of the. . .ftects ... be
ocmtrl.but.ory tutors

m productim

ot

fI'1ed~ 81

azoter1opatJl)".

Correlation between .trects ot epinephrine, norepinephrine,
t.bTradne, phentola1ll:1.ne and pbenoxy'benMJline en KNb8 C7C18 addatiem and the

abil1ty ot" the.. several drugs to llOdity incidence and e.,edty of subacutel;r
induced arter1alles1ms appeare to be cons1ltent with a bioohaioal bypoth..is of med.1al aclerog.es1a.

!hu, t.bTroxine wh1ch aupente epinephrine

arter1opathy, induced an increaae in ox1dat1m via the Krebs cycle.

Phentol-

amine which is reported to p1"OV1de protection against. subacute medial
arteriopatbT (O'SUllivan, 1.962) was quite effectiYe 1n 1nb.1bit1ng effeeta of

epinephrine on Krebs cyole metabol1snt.

Pbentolam1ne vu found to be more

potent in th18 regard tbat phccq'benzam1ne wb1ch 18 infer1Ol"
lacUo &i-t.

Norepinephl"me reported by F1"1edJun e\ &1.

U

(l9SSa,

a proph1'b) to be

la. eftectiYe in inducing med.1al. arter10patny \ban epinephrine did not.
produce any eignificant etrect en. Krebs cycle oxldati«t.

Although A'tP vas not

particulal"l¥ effectiYe 11'1 inhibiting etfeets ot epinephrine em carbohydrate

meta'bol1a, it was the . .t potent of the three drugs studied in rev81"8ing

1nhlblt,ion of protein syntbea18

CAUSed

by ep1nephrine.

It 18 the op1nion of th18 author that epinephrine arter10pathy is a

rather ccaplex pbanomenon which is the resultant of ....raJ, vect,o:ral factors.
Data 1n this report suggest that, greater weight be given to biochem1cal
faetora than ha.B been heretofore aacr1bed.

1be biochemical effects observed

follodng in-vitl"o incubatiGl of arteri.al tissue with epinephrine suggest that
th1a drug .". exert a biochemical act,ion

CIl

the genesu of medial arter1opatlv.

Such biochemical effects if' sufficiently intense could summate with oth..-

l.es1cm induCing tactol"8, thUB contributing to the genuis of Dl8d1al uteri-

opatl\Y'. It 1B possible that a b1oebem1cal les1(1'1 induoed by epinephr1ne
m1ght exert a pe1'ld.u:l.ve action on the 1nduot1C1l

tacton.

or

lee1on. by h81llOdynUl1c

Chapter VI
StImmal"Y

1. Subacute adldnistratim of' thyroJdne increased mUng s,yetolic and
diastol.1e pressure in the unanesthetized .rabbit but did not aign1ticantll'
augDIa'lt the pressor etf'ect of ep1nephrme.

2.

A'tP did not

slgnif'icant~

decrease the net increase 1n syatol1c pressure

follow1ng ep:inephrine in normal rabbits or

si~ficantl¥

alter the pressor

response to epinephrine in rabbi1;$ pretreated for two weeks with

3. Phctol_ne and phanaxyben.sud.ne, at

~ax1n

dOMe emplored, reduced pressOJ:"

effects of epinephrine to a s1mUar extant.

4.

Ipra:d.u1d did not signit1cantl¥ alter the preuor reapalse to epinephrine
in the rabbit.

S. ATP

and phentolam1ne reduced centrol systolic and d1utol1.o pnasu:ree to

a greater extet tluan did phenCDifbenH1l1ne.
6. Ability

or drugs

studied to modify the pressor reapmn toll.ou1ng

epinephrine adJrdn181:.ration in the rabblt did not. appear to correlate well
with their abUity to IIlOdif'y the incidence and sever1tT of epinephrine

arteriopatb7 as reported in the literature.
7. Epinephrine produced several Mtabol1c effects en rabbit aorUc tissue
such as depletion of tiaeue sl¥cogen, et1JmlatiCll of' oxidation via the

Krebs cycle, 1nh1biticn of oxidati<l1 'ria the hexose monophosphate shunt,

and inhibittcm of protein synthesis.

8. St:l..mnlat1m of Krebs c.rcle a:ddation tollOldng additJ.cm. of epinephrine to
rabbit aorta auggeets a poes1ble b1ochem1oal mode of' actim of' thia drug

an vaecular tissue.

9. Norep1nephrine which is reported to possess lesser aelerogenic potency
was leas effective than epinapbrine in st1mulat.1ng oxidation in arterial
t.issue.
10.

Both drugs produced s1m:U.ar increases in systolic pressure.

Augmentation of hmtoee monophosphate shunt activity by thyrax1ne

Wi\}"

explain l"8.Ported protective action against cholesterol atherosclerosis
by tb1a d.rug.

11. Inhibition of hexose monophosphate shunt activity may t!aPlain augmctatim by epinephrine of' intimal leaiona following cboleaterol feeding
reported by Cmstantinides (19S8).
12.

There appeared to be good correlatim between the ability of drugs
studied to augment or :tnbibit Kreba CTCle cm1dation and the ability of a
drug to intEnsity or amel10rate epinephrine arteriopath1'.

13. AfP which although less potent in inhibiting effects of epinephrine
car~te

metabol.1sm, reversed epinephrine induced inhibitlen

protein ayntheai. in t.b1rox1ne pretreated an1mala.

<1'1

or

ATP may act at more

than Q'le po1nt in 1nh1b1ting epinephrine aner1opatby.

14. Correlation betvem augmentation or 1nh1biticn of biochemical effects of
epinepbr1ne in rabblt aorta appears to be consistent with the role ot a
given drug in increasing or decreasing medial arter10patbT toll.owing

subacute adm1nistraticn ot ep1nephrine.

35.

Data preaented suggest that epinephrine produces medial arteriopatby in

the rabbit by a mecbaniam which may include biochemical effects on aortic

:metabol1lm.
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APPENDIX

Bray, G. A., AnaJ.. B1ochem. 1: 279-285 (1960).
Scintillation fluid for radioisotope experiments, was prepared as
follows:
60 €JIlS. Naptha1ene

4 £9ll8. PPO (2,5, dipheny1oxazole) scintillation grade
0.2

mn.

POPOP (1,4 ..bis-2(5 ..phenyloxazole)-benzene

scintillation grade
100 ml.
20 ml.

absolute methanol (AR grade)
ethylene glycol (AR grade)

Q.S. to 1 liter with p ..dioxane (scintillation grade) use

purest quality avallable commercially.

PPO and POPOP were obtained. fram Packard Instrument Canpany.

It was found that only the purest grade of dioxane could be used.
slnce analytical grade yellowed in the presence of HYam1ne-10X
and caused considerable quenching.

Buffer solutions used for incubation of aortic tissue in racUoisotope
exper1ments were prepared as described by Long (1961).

JCrebs-Ringer
phosphate

(KRP)

Krebs-Ringer
bicarbonate
(KW)

o.c;;, BaCl

100 mJ.s.

100 mls.

1.15~ XCl

4 m.l.8.

4 mls.

l.22J Cac~

3 mlS.

2.11~~

1 ml.

1 ml.

3.82~ MgS0

1 ml.

1 ml.

4

0.1 M l'fa2BP0

21 mls.

4
1.~ NaRC03*
,

* 1aBC03 solution was

saturated with CO2 before addition to prevent

precipitation of calcium.
Prior to use buffers were gassed Wi th 1~ oxygen for the Krebs-Ringer
Phosphate butfer or 5j CO2 95~ O2 for the Krebs-Ringer Bicarbonate
buffer.

Inoren1c and Labile PhQSPbate Determination
Method used was that described by Fiske and SubbaRov (1929).
~

principle of the method is based on the formation of a ph08phanolyb-

date camplex With inorganic phosphate and molybdate ion in the presence

of sulfurtc aCid.

Reagents:

5 J Sultur1c acid (reagent grade).
2.51r ammonium molybdate.

Bed.ucing reagent prepared in powdered fom and stored in dessieator.
Contained 0.2 f!Iil .. of 1 amino.. 2-napthol-4 .. sulfonic aCid, 1.2 €Pl- sodium
bisulfite and 1.2

sm.

sodium sulfite.

powder with a mortar and pestle.

The mixture was ground to a fine

For use, 0.25 gm. of powdered reagent

was dissolved in 10 m.ls. at distilled vater prior to use.
Standard solution concentrate containing 1.3613 p •.~ in 1 L. of

distilled water wu prepared.

For use as a standard this solution was

diluted 1:10 so that it contained 1 mieromole of phosphate per ml.
Tissues were deproteinized u

cedu.re.

deSCribed in lactic acid pro-

A 0.5 ml. aliquot of this supernatant vas used.

To the unknOWn

sample 1 ml. ot sulfuric acid was added, followed by 1 IDl. of the ammonium
molybdate solution.

After mixing, 0.1 ml. of reducing solution was added

and volume adjusted to 10 mla. by addition of' distilled vater.

After 10

minutes optical density 'Was measured. at 660 mu. in a Bectlmlan DU spectra..
photaueter.

In procedure for analysis of lab11e phosphate sult'u.r1c acid

vas added to unknown and volume adjusted to 5 mls.

Samples were then heated in a boiling vater bath tor seven minutes, cooled
•
and then addition of molybdate and reducing solution vas carried. out. As

a final step the volume was adjusted to 10 mls.
described above after 10 minutes.

Samples were read as

In all analysis standards containing

1.0, 0.5 and 0.25 uM phosphate were also processed and calibration curve
used to ex .. rapolate results.

Labile phOsphate was calculated by sub-

tract1ng values for inorganic phosphate from. labile phosphate values.

Lactic Acid Determination. Method of Barker & Summerson (l~l)
The method is based on the quantitative conversion

~

lactic

acid into acotaldeb¥de \lben beated in concentrated sulf'uric acid.
aoetald~

!l'he

formed is determined via formation of a purple colored

complex wi tb lVdroxy diphenyl.

Reagents:
Acid (Reagent grade).

4~ Solution

01'

~.

1.5; Solution

5B:zO.

Concentrated Sulfuric

of p-bydroxydiphenyl in 0.5j HaOH.

Lactate standard.
Suhsequent to

l~val

of tissues fx-om. the a.n1mal the weighed.

sample W8 hanogenized in a Pot-ter Ilvehem type glus bcmogenizer, immersed
in an ice bath.

In all cases the tissue sample wu 1mmernd in 2.5 cc. of

ice cold distilled water for hClnogenization and the resultant supernatant
freed of cellular debris was processed as suggested by Barker and Summerson.

Alec. aliquot was deproteinized by add1 t10n of 1 co. of l~ 1'CA and the
supernatant used for dete:t:mination of tissue lactic acid.
aliquot used vas usually 0.2 mls.
by addition of distilled water.

The size of

This 'Was adjusted up to a volume of 1 cc.
To the test tube contain1ng this aliquot in

a volUl'!1e of lee., 1 drop of 4~ ~ wu added, and the tube ehilled in an
ice ba·th.

Af'ter equilibration, eold concentrated sulfuric acid was added

trom a pipetting

8yTi~~

set at 6 mla.

swirled to m1nim:1ze heating.

During addition of aCid, tUbe waa

1'hi8 swirling was continued until tube and contents were approx1mately
at room t.en;>erat.ure.

When additlon of' reagents to all tubes i:n the s6r1es

waa cCBpleted,t1'.l.e tubes were withdrawn tram the ice

'bath ln wbioh they

'Were stored and heated in a bolling vater batb for 5 minutes.
On

~val.

to bela., 200(:.

:fran the boU1:ng vater bath, they were aga1n cooled

Two Uraj:l" of the p·b;ydroJQd1plleuyl reagent were a4ded fram

a 1 ml. pipet'te (0.1 &l.) and the reagent dispersed by stlrr1:ng 111 th a th1:n
glasa l'od.

'rlw tUbes ",ere then "aged II tor 30 m1:nutea in a water- bath at

25°C room ~r&ture.

DuriJlg this period the prec1pitated p-h,ydroxy-

diphelQ"l reagent was resuspeDiad at least three time..

30 minute

pel~iod

At the end of the

the excess p .. by~pheDyl reagent was destroyed by

heat1.'a.8 the tubes in boiling water for 90 secontla and then recooling.

Color developmen;t was _asured in a Beclulan DU speotrophotameter at
Prior to reading of Nolilples the instrument
dens1t~

'VU

by use of a sulturic acid blank, in

Summerson t 8 recamnendat1on.

adJusted to

acco~c.

Zftl'O

optical

with Barker and

Along with each seri.. of Ul'lknotms a calibra-

tion curve was established 'WIling knu.m uauntll of a(:-1010 acid.
prepared to contain 2, It and

'l'bese were

6 meg. of lactic ac14 per tube. 1w::! samples

''''bich gave Nad1ugs in a range beyond an O.D. of 0.600 were rerun a't
higher dilution.

560 :m.u.

Lactic De&grggepue

'LOR) As"!l -

for use in arterial tissue.

Kittinaer et 81. (1960).
The prinCiple of the method is based on the oxidation of l'P0
and reduction of pyruvic to lactic acid.

band at

340 mu.

D.PD has a strong absorption

wbile II'1I absorbs very little at this wave lenth.

'l'hus,

clJange in optical deMity is proportional to oxidation of DPII.

lleagents:

-~

4 x 10 - M •

-4

Pyruvate, 1.2 x 10

M !PD, 0 .. 1 M phosphate

butter pi T.8.
Pieces of aortic or skeletal muscle tiseue were ha.nogen1zed
as previously described 1n the lactiC I1ci4 analytical method.

volume of saline uae4 was 2.5 mls.
:f'Ugation f'or 10 m1mltes at 3000 rpm.

Totul

Homogenate was cleared by centriThe f'011ow1ug reagents veloe a4ded

to a Beekman JlJ cuvette centrirtlge tube 1) 0.1 ml. of' .&Pyruvate,

2) 0.1 ti. of J.l'1I and 3) 2.75 ml. p!lospbate butter.

This solutior!

was It,irre4 with a tine glUe rod and 0.05 al. of' tissue haaogeMte

supernatent were added and apin the contents were stirred.

The

re-

suttant solution was rapidly placed in a :Beckman DU spectrophotameter
and change in optical Cf.er18ity recOl'ded at 30 second. intervals, for a

period of three minutes.

Rate of cbo.nge in optical density wss can,"

pared with standard

obtained by adding varytllg amounts of DPJH to

C"I1rV"e

the butter system described above.

Activity

sul;,.trate reacting per unit

01'

oxidation of 1 JD1eraaole

!)PH per minute.

tor dilution

01'

and tissue weight.

'Wt.UJ

expressed as rate of

time, one unit being equivalent to
All data.

W*l'8

correct..i

Glucose Determination (Glucose Ox1dase Procedure)
This procedure is based on the ox1dat1on of glucose via
glucose oxidase forming

~~

and glucon1c ac1d.

The peroxide tom d

ox1dizes a chrauogen which in reduced torm does not absorb at 400 mu.
Real:;ent:

Glucostat reagent, Worthington Biochemical Corp., Freebold,

N. J. was dissolved in distilled water and chromogen added.

The final

volume was adjusted to 98 ml. in accordance with the manufacturers
instructions.
Deproteini~ed

solution was obtained by treating tissue

homogenate or blood wi tb 1 ml. each of the Somogyi reagents (2. ~

ZnS04°7J:il:2O and 1.8~ Ba(OHr.2).

Thus, blood was processed by adding

0.2 ti. of whole blood to l.B BIl. of H2O, and 1 rol. of each of the

Somogyi reagents was added.

Tissue extract was prepared by

homogenization in distilled water in a volume of 5 mls.

A 2 rol.

aliquot of the f'iltrate was then processed as described for blood
with

add1t~ion

of 1 ml. of each of the Sau.ogyi reagents.

Color DevelOj?tnent
Two mls. of the tissue extract were placed in a test tube,

8.0 mls. of glucose oxidose reagent were then

added and the resultant

solution was incubated at 3rfC tor 30 minutes.

At th1s point one drop

of 4nCl was added to each tube to stop the react1on.
read. 1n a Beckman 00. spectrophotometer at 400 mu.

at lO~ transmission by use of a reagent blank.

Samples were then

Instrument was set

A calibration curve

waa establiahed USing known amounts of glucose tor each series of
determinations.

Protein Detem1nations
.F .......

_~

Protein va. detel'ldned by the method described by Gornal eft &1. (19ft-8).
The method i. baaed on tbe toxmatj,on of a vIolet color when

proteiJW or polypetides containing aa14e or pepti4e linkage. react Vi th

copper aultate in a strongly al kaUne solut1on.

ieagenta&
following.

Biuret reagent (00rDa.ll et al, 19lt8) conta1n1~ the

1.5 19B. cupr1c .ulfate (~. 5¥). 6.0

sm.

pote.aaium

tartrate (1aICC4,06* ~ ~O) 41&8olved. in approx1mateq 500 ml.. of

cUst111ed water to Which is added. 300 ml. of l~ IaOB.

Q.S. to 1 lIter.

ODe ml. of tis.ue Supenw.tant, obtained by haaoprd.z1ng 40 to
100 mg. of tis.ue in 5 ml. of distilled water and. centrtfu3\tIon at 3000

rpm. tor 15 minutea vas placed in a 12 ml. centrtt'ub... tube.

'l'o thU waa

added .. ml. of bIuret reagent and the resultant solution WIllS allowecl to

stard for 30 minute. at rocm

~rature.

Unknowns aDd stan4ar48 were

react in a Beckman 00 apectrophotam.eter at 540
with 41et1Ue4 vater.

lIN ..

adjusted to &ere O.D.

Bea&ent blank and proteIn standarda ",.re uae4. as

OODtrol& 11'1 each n1"1.. of ana.lysis.

Protein staD4al'd was obtaine4 tr=

Da4e reagents (Lab-'rrol) a:od adJuste4 to contain .083*, o.16151t and
0.2515~ of protein in each reapect1ve sample.

Procedure follow eel vas essentially that described by Seitter
et ale (1950).

1'bis method is a modification of the procedure of Good

et al. (1933).
Principle of the method involvu the separat.ion of glycogen

:fran tissue and other conta.m1nanta I bydrolya1s of glycogen to glucose
aDd determination of glucose present by the development ot color vi th

anthrone reagent.
Reagents:

~ lOB,

95; sulfuric acid

95j ethanol, 60j ethanol, O.2~ anthrone in

(reagent grade).

Aortic ancl skeletal muscle tissuea were rapidly excised fran
rabbits, veighed on a Mettler 'balance, and placed in a test tube contaiD1ng 1 1Dl. of :JJ1, KOB.

The test tube vas then placed in a boiling

vater bath and heated for twenty minutes.
tube vas allowed to cool to
added.

l"OCD

At the end of this t1me, the

temperature and 1.25 mla. of 95~ ethanol

Contents were D'l1xeIi with the aid of a thin glass rod which vas

rinsed wi th 6~ ethanol which was ad4ed to the contents of the tube.

i'he sample

was then heated to boiling in a vater bath, cool.eel

temperature aDd centri1'uged tor 15 minutes at 3000 rpm.

to room

The su;pernatant

was decanted and the precipitate redissolved in 1 ml. ot distilled water aDd
rep:recipitated as described above.

rus procedure vas repeated twice.

In preparation tor analysis the sample of glycogen vas dissolved in 2., mls.

ot distilled water

and cooled in an ice bath.

Cold anthrone rea.gent was then added fran a pipetting syringe and the
contents of the tube swirled in the ice bath.

The tube containing

glycogen and anthrone reagent vere "capped II with glass marbles and
heated in a boiling water bath for 10 minutes.

Samples were then

cooled and stirred with a thin glass rod and read at 620 mu. in a

Beckman DU spectl'Ophotometer.
lnstrument iD zero O.D.

A reagent blank was used to adjust the

Standards containing 10, 20 and 50 micrograms

of glucose were also run with each set of unknowns.

Tissue samples

used in the ana.l.ysi& varied from about 40 to 100 mg. depending on

ava1la.bi1ity.

)!'.

Incubation Flasks
Problems aasooiated with clew 116 of Warburg f'laaks in :rad10-

iSotope exrAriments are particularly disconcerting since not only mu.o;t

the ve8sel be chemically clean but

I!ll.Ult alBO be free of radioisotopes

vb1cb when present in onl7 trace quantities are 11kel7 to alter results
significantly.

Dur1.ng

the ratio1sotope

the coune of pilot cxper..m.ente pl"elim1ntIU"Y to

~&l"1!:lentG

described in this

l'ePOl."'C

the d.esil'abiU ty

of bav1118 a tfdisposable Vali:n.t.r" fl.a.&k" becamo eVident.

As a. I.'Etsult a

disposable metabol.1ea fluk. W&II developed, aa1 ia pictured em tbe sub...
• equent page..

The aomponenta are ratber 1ne.x;ponsiw, total c.'Out be1ug

in the noigbborhood of twlw cents, aDd arc rea4ily available u

1teaa from DlO8t scientific 8'\loWly house8.

'fbeH are:

1.

Serum vial stoppers (rubber).

2.

Disposable plastic "D1spo" beakers (2 ml.).

3. Copper Vire 22 e;auge.

4. l'11ter paper.
,.

Disposable glas. count1ng vials.

As&embly procedure 1$ ae follove:
1.

Fold filter paper :111 ehapo ot fluted stan approximately

3/1.6" hlp aDd v:1th a ra41,. ot 7/16". A

three la;ye:rec1

to14 vas f'0un.4 to have Iat1stactor;y absol.'1)anoy.

2.

Pierce d1apOH.ble plutlc beakel"8 W1th • red hot 23 gause
DM4le 80 as to produce two holes at appoai te ends of tbe
the top of the b-.lter.

stock

3.

Plaee f:1lter paper into bottan of' beakers and "tie"
the beaker vi th eopper wire (a8 per photOgl"e.ph).

4.

Thread $1I11Q1ng end

or

copper w1re through hole

prev:1oua17 punched through bott(lJl of l.ower margin Of
l'Ubber serum vi.$l8topper.SUpott any rema1n1ng
~

with

v1~

cutter.

Prior to \l.8e 0.2 ml~ of 4. B KOIl 18 applied onto the

til tel" paper in the beaker taldns care pot to touch sides.

A

'.l'he counting vtala were pretille4. With previousl¥ gus.

butter and. ra410activa substrate prior to use.
cleaDed

am

After tissue samples vere

weighed the plaat10 cap on the counting vial contain1ng

butter vas 1W1O'V'e4 and tissue sa.mplea placed in the medium.

bs. glass

vials were \hen placed in a _tabol1c abaker and SU .... via a manito14 to
vhich 18 gauge 1l8e4le. wen attached
nee4le

~

~or

eutry of ox,.Pfl UJ4 a eec0a4

extt of air l'Ilixture. After appropriate peeing

the serum

vial stoppers (With attache4 beaker coata1aSag KOa) were rap14ly attlxed.

and a441 tlOD of 4Nga

~

vas a44e4 via a 23 sause ~c

vial va then sba1um on

speed.

pertozme4 by iDJeotlOD throu&b the rubber

When it vaa desired. to te:na1Jate the 1DcubatiOl1 0.5 ml. of

stopper.

4•

1fU

aD

..u. and syr1Dge.

i'.be

lbel"bacll sbaker for twenty m1mttes at low

At tld.a t t . the viall were

~

from the IJhak1ng apparatwa,

the GaPs lemoved aDd the plutte beakers vuhe4 vith 1 JIl. of 41still.ecl

vater wbich vu al.l.cM!Id to flow Into the vial.
then

~

ftssue aa.mples vere

aD4 the vial contaSning me41_ .... nd1oact1ve substrate

vas capped With a plat1e som cap aDd atored 1a a freezer tor
ad4it1C1lal aualya1••

beaker (bans:1ns traa the . .nil v1al cap) 0.1 JIl. of
1; 'fr1ton )200 vas a44ed to ..sure wettins aa4 l'elease of cl40 trapped
2
'to each

by the KOBO'

'1'he S8rua vial stopper vas then placed atop .. MeODd. vial

CODta1n1q 0., al. of JfJam1ne 10 X.

Acid (0.4 Btl.

or 4

acI4e4 to the 'beaker by 1nJectton throus,b the rubber

to etteat release of the c1~ which

YU

I' ~so..) was

"1'\111 vial cap,

tbAn bOWl4 by the II1a1ne.

to eftect releaae of the cl~ which was then bound by the lJ1am1ne.

After

.baking tor an additional. 30 minutes the .arum vial cap vas removed and

10 mla. of Bray's solution added.

The vial vas then capped witb

a plastic

screw cap and counted in a Packard llquid Scintillation Counter.
During the course of development of this procedure yield and
linear! ty of Cl~ trapping

was determined by use

of radioacti ve 1Ia2C1~.

Canpa:rison of triplicate samples containing 0.0125, 0.025 and 0.05 uC per
vial disclosed tbat the average variation between triplicate samples
Data comparing yield and reproducibility for this pro-

averaged 2.2j,.

ce4w:e aD1 for an alternate method using conventional Wa,n,urg flasks is

tabulated below:

"Disposable War'burg

Conventional War'burg

nash.

Flask"

Precision*

~

Yie14

Pnc1aica*

j Yielc1

0.0125

C

l.~

l.22

3.8

110

0.025

C

4.2j

111

0.8

16

0.050

C

0.4j

105

11.1

90

1.9j

114

5.2

92

Average

* Percentage

variation between triplicate samples.

j yield was calculated va ~cl4~ counted in Bray·s .olution.
'l'be difficult solubilit7 of this salt in the scintillation med.ium is in

our o.pin1on responsible tor the yield in excess of looj ob••rvecl.

In

~'\I1ID8.ry I

the "disposable Warburg flask It

desoribed

apr-ea1"8" fran this author'. experience to bave the following
aci'VlUltage8 over and. abOve the conventional. War'burg flask when

used tor radioisotope experiments:
1.

Greater

acevacy. 2. Allows pretlUing of v1alJJ which

can be ccmven1ently 8tOred.

3. Although aaaewbat more expensive

this prooedure allowed HOIlCIYIY of tiM

ordinary V!U'bUrg flasks.

4.

~

spent cleaning

Greater 81l11pllc1ty of bandllng -

elJm1lJ1!1t1on Of volUlll8triC transfer'S • _s- 1'eaOftl of KOB

well at Warburg fla&k 8l'l4 the

lSeftral

c<Dp1ete :removal ot trapped Cl~.

trca center

r1D81DC8 De_seary to ettect

5. Allove4 a greater number

of experiments to be conducted nch working

4aT.

It should be eeg;>hU1ze4 that the proce4un described.
above 1e ~ su1tabl.e tor uae when DJfiI.UQD.e'tl'ic _thoda aft aploye4.
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